BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365:1073-1086. [PMID: 15781103 DOI: 10.1016/s0140-6736(05)71144-2] [Cited by in Crossref: 269] [Cited by in F6Publishing: 536] [Article Influence: 15.8] [Reference Citation Analysis]
Number Citing Articles
1 Sakuma C, Sekizuka T, Kuroda M, Hanada K, Yamaji T. Identification of SYS1 as a Host Factor Required for Shiga Toxin-Mediated Cytotoxicity in Vero Cells. Int J Mol Sci 2021;22:4936. [PMID: 34066520 DOI: 10.3390/ijms22094936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Hermos CR, Janineh M, Han LL, McAdam AJ. Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol 2011;49:955-9. [PMID: 21177902 DOI: 10.1128/JCM.02119-10] [Cited by in Crossref: 43] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
3 Cheung V, Trachtman H. Hemolytic uremic syndrome: toxins, vessels, and inflammation. Front Med (Lausanne) 2014;1:42. [PMID: 25593915 DOI: 10.3389/fmed.2014.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Lee MS, Kwon H, Lee EY, Kim DJ, Park JH, Tesh VL, Oh TK, Kim MH. Shiga Toxins Activate the NLRP3 Inflammasome Pathway To Promote Both Production of the Proinflammatory Cytokine Interleukin-1β and Apoptotic Cell Death. Infect Immun 2016;84:172-86. [PMID: 26502906 DOI: 10.1128/IAI.01095-15] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 4.9] [Reference Citation Analysis]
5 Thomas DE, Elliott EJ. Interventions for preventing diarrhea-associated hemolytic uremic syndrome: systematic review. BMC Public Health 2013;13:799. [PMID: 24007265 DOI: 10.1186/1471-2458-13-799] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
6 Beczkiewicz ATE, Scharff RL, Kowalcyk BB. Facilitating Evaluation of Hemolytic Uremic Syndrome Long-Term Health Outcomes Through Social Media Support Groups. Front Public Health 2020;8:544154. [PMID: 33330302 DOI: 10.3389/fpubh.2020.544154] [Reference Citation Analysis]
7 Ma Y, Chen J, Fong K, Nadya S, Allen K, Laing C, Ziebell K, Topp E, Carroll LM, Wiedmann M, Delaquis P, Wang S. Antibiotic Resistance in Shiga Toxigenic Escherichia coli Isolates from Surface Waters and Sediments in a Mixed Use Urban Agricultural Landscape. Antibiotics (Basel) 2021;10:237. [PMID: 33652953 DOI: 10.3390/antibiotics10030237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nagy A, Mowery J, Bauchan GR, Wang L, Nichols-Russell L, Nou X. Role of Extracellular Structures of Escherichia coli O157:H7 in Initial Attachment to Biotic and Abiotic Surfaces. Appl Environ Microbiol 2015;81:4720-7. [PMID: 25956766 DOI: 10.1128/AEM.00215-15] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
9 Fitz-Gibbon S, Tomida S, Chiu BH, Nguyen L, Du C, Liu M, Elashoff D, Erfe MC, Loncaric A, Kim J, Modlin RL, Miller JF, Sodergren E, Craft N, Weinstock GM, Li H. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013;133:2152-60. [PMID: 23337890 DOI: 10.1038/jid.2013.21] [Cited by in Crossref: 335] [Cited by in F6Publishing: 288] [Article Influence: 37.2] [Reference Citation Analysis]
10 Bauwens A, Kunsmann L, Karch H, Mellmann A, Bielaszewska M. Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7. Antimicrob Agents Chemother 2017;61:e00937-17. [PMID: 28607018 DOI: 10.1128/AAC.00937-17] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 4.6] [Reference Citation Analysis]
11 Lino M, Kus JV, Tran SL, Naqvi Z, Binnington B, Goodman SD, Segall AM, Barnett Foster D. A novel antimicrobial peptide significantly enhances acid-induced killing of Shiga toxin-producing Escherichia coli O157 and non-O157 serotypes. Microbiology (Reading) 2011;157:1768-75. [PMID: 21454368 DOI: 10.1099/mic.0.047365-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
12 Shen-Tu G, Kim H, Liu M, Johnson-Henry KC, Sherman PM. Protein kinase C mediates enterohemorrhagic Escherichia coli O157:H7-induced attaching and effacing lesions. Infect Immun 2014;82:1648-56. [PMID: 24491575 DOI: 10.1128/IAI.00534-13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
13 Hazen TH, Donnenberg MS, Panchalingam S, Antonio M, Hossain A, Mandomando I, Ochieng JB, Ramamurthy T, Tamboura B, Qureshi S, Quadri F, Zaidi A, Kotloff KL, Levine MM, Barry EM, Kaper JB, Rasko DA, Nataro JP. Genomic diversity of EPEC associated with clinical presentations of differing severity. Nat Microbiol 2016;1:15014. [PMID: 27571975 DOI: 10.1038/nmicrobiol.2015.14] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 7.7] [Reference Citation Analysis]
14 Senthakumaran T, Brandal LT, Lindstedt BA, Jørgensen SB, Charnock C, Tunsjø HS. Implications of stx loss for clinical diagnostics of Shiga toxin-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 2018;37:2361-70. [PMID: 30267169 DOI: 10.1007/s10096-018-3384-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
15 Lewis SB, Cook V, Tighe R, Schüller S. Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo. Infect Immun 2015;83:942-9. [PMID: 25534942 DOI: 10.1128/IAI.02928-14] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
16 McHugh RE, O'Boyle N, Connolly JPR, Hoskisson PA, Roe AJ. Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis. Infect Immun 2019;87:e00595-18. [PMID: 30455200 DOI: 10.1128/IAI.00595-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Werber D, Krause G, Frank C, Fruth A, Flieger A, Mielke M, Schaade L, Stark K. Outbreaks of virulent diarrheagenic Escherichia coli--are we in control? BMC Med 2012;10:11. [PMID: 22300479 DOI: 10.1186/1741-7015-10-11] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
18 Canpolat N. Hemolytic uremic syndrome. Turk Pediatri Ars 2015;50:73-82. [PMID: 26265890 DOI: 10.5152/tpa.2015.2297] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
19 Beutel G, Kielstein JT, Ganser A. [Thrombotic microangiopathy]. Internist (Berl) 2013;54:1070-9. [PMID: 23974913 DOI: 10.1007/s00108-013-3261-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Church DL, Emshey D, Semeniuk H, Lloyd T, Pitout JD. Evaluation of BBL CHROMagar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory. J Clin Microbiol 2007;45:3098-100. [PMID: 17634298 DOI: 10.1128/JCM.00426-07] [Cited by in Crossref: 30] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
21 Morinaga N, Yahiro K, Matsuura G, Moss J, Noda M. Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1. Cell Microbiol 2008;10:921-9. [PMID: 18005237 DOI: 10.1111/j.1462-5822.2007.01094.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
22 Stearns-Kurosawa DJ, Oh SY, Cherla RP, Lee MS, Tesh VL, Papin J, Henderson J, Kurosawa S. Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome. Am J Pathol 2013;182:1227-38. [PMID: 23402998 DOI: 10.1016/j.ajpath.2012.12.026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
23 Hostetter SJ, Helgerson AF, Paton JC, Paton AW, Cornick NA. Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome. BMC Res Notes 2014;7:331. [PMID: 24890228 DOI: 10.1186/1756-0500-7-331] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
24 Bielaszewska M, Middendorf B, Tarr PI, Zhang W, Prager R, Aldick T, Dobrindt U, Karch H, Mellmann A. Chromosomal instability in enterohaemorrhagic Escherichia coli O157:H7: impact on adherence, tellurite resistance and colony phenotype. Mol Microbiol 2011;79:1024-44. [PMID: 21299654 DOI: 10.1111/j.1365-2958.2010.07499.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
25 Wijnsma KL, Veissi ST, de Wijs S, van der Velden T, Volokhina EB, Wagener FADTG, van de Kar NCAJ, van den Heuvel LP. Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome. Front Immunol 2020;11:547406. [PMID: 33414780 DOI: 10.3389/fimmu.2020.547406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Brando RJ, Miliwebsky E, Bentancor L, Deza N, Baschkier A, Ramos MV, Fernández GC, Meiss R, Rivas M, Palermo MS. Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains. Clin Exp Immunol 2008;153:297-306. [PMID: 18549440 DOI: 10.1111/j.1365-2249.2008.03698.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
27 Dunière L, Gleizal A, Chaucheyras-Durand F, Chevallier I, Thévenot-Sergentet D. Fate of Escherichia coli O26 in corn silage experimentally contaminated at ensiling, at silo opening, or after aerobic exposure, and protective effect of various bacterial inoculants. Appl Environ Microbiol 2011;77:8696-704. [PMID: 21984243 DOI: 10.1128/AEM.06320-11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
28 Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lämmle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012;120:1157-64. [PMID: 22611154 DOI: 10.1182/blood-2012-02-412197] [Cited by in Crossref: 162] [Cited by in F6Publishing: 158] [Article Influence: 16.2] [Reference Citation Analysis]
29 Karch H, Denamur E, Dobrindt U, Finlay BB, Hengge R, Johannes L, Ron EZ, Tønjum T, Sansonetti PJ, Vicente M. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med 2012;4:841-8. [PMID: 22927122 DOI: 10.1002/emmm.201201662] [Cited by in Crossref: 172] [Cited by in F6Publishing: 145] [Article Influence: 17.2] [Reference Citation Analysis]
30 Loconsole D, Giordano M, Laforgia N, Torres D, Santangelo L, Carbone V, Parisi A, Quarto M, Scavia G, Chironna M; Bloody Diarrhea Apulia Working Group. Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. Eur J Clin Microbiol Infect Dis 2020;39:539-47. [PMID: 31776873 DOI: 10.1007/s10096-019-03755-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
31 Tsai HM. The molecular biology of thrombotic microangiopathy. Kidney Int 2006;70:16-23. [PMID: 16760911 DOI: 10.1038/sj.ki.5001535] [Cited by in Crossref: 76] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
32 Albersmeier JP, Bremer JP, Dammermann W, Lüth S, Hagenmüller F, Rüther C, Otto H, Nielsen AM, Schumacher U, Ullrich S. Outcome and clinical course of EHEC O104 infection in hospitalized patients: A prospective single center study. PLoS One 2018;13:e0191544. [PMID: 29420567 DOI: 10.1371/journal.pone.0191544] [Reference Citation Analysis]
33 Pollock KG, Bhojani S, Beattie TJ, Allison L, Hanson M, Locking ME, Cowden JM. Highly virulent Escherichia coli O26, Scotland. Emerg Infect Dis 2011;17:1777-9. [PMID: 21888827 DOI: 10.3201/eid1709.110199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
34 Porubsky S, Federico G, Müthing J, Jennemann R, Gretz N, Büttner S, Obermüller N, Jung O, Hauser IA, Gröne E, Geiger H, Gröne HJ, Betz C. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure. J Pathol 2014;234:120-33. [PMID: 24909663 DOI: 10.1002/path.4388] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
35 Geramita MA, Hofer J, Cooper J, Moritz ML. Decreased severity of Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS) in a child with type 1 von Willebrand disease. BMJ Case Rep 2017;2017:bcr-2017-221043. [PMID: 28855217 DOI: 10.1136/bcr-2017-221043] [Reference Citation Analysis]
36 Detzner J, Krojnewski E, Pohlentz G, Steil D, Humpf HU, Mellmann A, Karch H, Müthing J. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity. Toxins (Basel) 2021;13:139. [PMID: 33673393 DOI: 10.3390/toxins13020139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Armstrong CM, Ruth LE, Capobianco JA, Strobaugh TP Jr, Rubio FM, Gehring AG. Detection of Shiga Toxin 2 Produced by Escherichia coli in Foods Using a Novel AlphaLISA. Toxins (Basel) 2018;10:E422. [PMID: 30360508 DOI: 10.3390/toxins10110422] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
38 Tanquilut CD, Jung CW, Nelson AW, Lau SK. Infection due to Shiga toxin-producing enterohemorrhagic Escherichia coli (EHEC) presenting as ischemic colitis. IDCases 2019;18:e00629. [PMID: 31528540 DOI: 10.1016/j.idcr.2019.e00629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Petruzziello-Pellegrini TN, Yuen DA, Page AV, Patel S, Soltyk AM, Matouk CC, Wong DK, Turgeon PJ, Fish JE, Ho JJ, Steer BM, Khajoee V, Tigdi J, Lee WL, Motto DG, Advani A, Gilbert RE, Karumanchi SA, Robinson LA, Tarr PI, Liles WC, Brunton JL, Marsden PA. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 2012;122:759-76. [PMID: 22232208 DOI: 10.1172/JCI57313] [Cited by in Crossref: 75] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
40 Golan L, Gonen E, Yagel S, Rosenshine I, Shpigel NY. Enterohemorrhagic Escherichia coli induce attaching and effacing lesions and hemorrhagic colitis in human and bovine intestinal xenograft models. Dis Model Mech 2011;4:86-94. [PMID: 20959635 DOI: 10.1242/dmm.005777] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
41 Petro CD, Trojnar E, Sinclair J, Liu ZM, Smith M, O'Brien AD, Melton-Celsa A. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a In Vivo and In Vitro. Infect Immun 2019;87:e00787-18. [PMID: 30670557 DOI: 10.1128/IAI.00787-18] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
42 Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T. Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement. Medicine (Baltimore) 2015;94:e1000. [PMID: 26091445 DOI: 10.1097/MD.0000000000001000] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
43 Bonetti V, Mangia CM, Zuza JM, Barcelos MO, Fonseca MM, Nery SP, Carvalhaes JT, Andrade MC. Hemolytic-Uremic Syndrome in Uberlândia, MG, Brazil. ISRN Pediatr 2011;2011:651749. [PMID: 22389782 DOI: 10.5402/2011/651749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Islam N, Nagy A, Garrett WM, Shelton D, Cooper B, Nou X. Different Cellular Origins and Functions of Extracellular Proteins from Escherichia coli O157:H7 and O104:H4 as Determined by Comparative Proteomic Analysis. Appl Environ Microbiol 2016;82:4371-8. [PMID: 27208096 DOI: 10.1128/AEM.00977-16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
45 Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol 2010;85:844-7. [PMID: 20799358 DOI: 10.1002/ajh.21833] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
46 Choi KS, Kim SH, Kim ED, Lee SH, Han SJ, Yoon S, Chang KT, Seo KY. Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles. PLoS One 2014;9:e100229. [PMID: 25032703 DOI: 10.1371/journal.pone.0100229] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
47 Fischer FB, Saucy A, Schmutz C, Mäusezahl D. Do changes in STEC diagnostics mislead interpretation of disease surveillance data in Switzerland? Time trends in positivity, 2007 to 2016. Euro Surveill 2020;25. [PMID: 32820716 DOI: 10.2807/1560-7917.ES.2020.25.33.1900584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Capps KM, Ludwig JB, Shridhar PB, Shi X, Roberts E, DebRoy C, Cernicchiaro N, Phebus RK, Bai J, Nagaraja TG. Identification, Shiga toxin subtypes and prevalence of minor serogroups of Shiga toxin-producing Escherichia coli in feedlot cattle feces. Sci Rep 2021;11:8601. [PMID: 33883564 DOI: 10.1038/s41598-021-87544-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Mejias MP, Cabrera G, Fernández-Brando RJ, Baschkier A, Ghersi G, Abrey-Recalde MJ, Miliwebsky E, Meiss R, Goldbaum F, Zylberman V, Rivas M, Palermo MS. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera. Infect Immun 2014;82:1491-9. [PMID: 24421050 DOI: 10.1128/IAI.00027-14] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
50 Barnard E, Shi B, Kang D, Craft N, Li H. The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci Rep 2016;6:39491. [PMID: 28000755 DOI: 10.1038/srep39491] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 12.3] [Reference Citation Analysis]
51 Stromberg ZR, Masonbrink RE, Mellata M. Transcriptomic Analysis of Shiga Toxin-Producing Escherichia coli during Initial Contact with Cattle Colonic Explants. Microorganisms 2020;8:E1662. [PMID: 33120988 DOI: 10.3390/microorganisms8111662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Barnett Foster D. Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence 2013;4:315-23. [PMID: 23552827 DOI: 10.4161/viru.24318] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
53 Strachan NJ, Rotariu O, Lopes B, MacRae M, Fairley S, Laing C, Gannon V, Allison LJ, Hanson MF, Dallman T, Ashton P, Franz E, van Hoek AH, French NP, George T, Biggs PJ, Forbes KJ. Whole Genome Sequencing demonstrates that Geographic Variation of Escherichia coli O157 Genotypes Dominates Host Association. Sci Rep 2015;5:14145. [PMID: 26442781 DOI: 10.1038/srep14145] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
54 Thurman JM, Marians R, Emlen W, Wood S, Smith C, Akana H, Holers VM, Lesser M, Kline M, Hoffman C. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol. 2009;4:1920-1924. [PMID: 19820137 DOI: 10.2215/cjn.02730409] [Cited by in Crossref: 129] [Cited by in F6Publishing: 66] [Article Influence: 9.9] [Reference Citation Analysis]
55 Lienemann T, Salo E, Rimhanen-Finne R, Rönnholm K, Taimisto M, Hirvonen JJ, Tarkka E, Kuusi M, Siitonen A. Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009. Emerg Infect Dis 2012;18:577-81. [PMID: 22469631 DOI: 10.3201/eid1804.111310] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
56 Hauswaldt S, Nitschke M, Sayk F, Solbach W, Knobloch JK. Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coli. Curr Infect Dis Rep 2013;15:4-9. [PMID: 23212721 DOI: 10.1007/s11908-012-0302-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
57 Naïli I, Gardette M, Garrivier A, Daniel J, Desvaux M, Pizza M, Gobert A, Marchal T, Loukiadis E, Jubelin G. Interplay between enterohaemorrhagic Escherichia coli and nitric oxide during the infectious process. Emerg Microbes Infect 2020;9:1065-76. [PMID: 32459575 DOI: 10.1080/22221751.2020.1768804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Kouzy R, Alawieh R, Sukhon F, Temraz S. A Case of Typical Hemolytic Uremic Syndrome in an Adult. Cureus 2018;10:e3289. [PMID: 30443459 DOI: 10.7759/cureus.3289] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Saenz JB, Li J, Haslam DB. The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response. Cell Microbiol 2010;12:516-29. [PMID: 19951368 DOI: 10.1111/j.1462-5822.2009.01414.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
60 Johansson K, Willysson A, Kristoffersson AC, Tontanahal A, Gillet D, Ståhl AL, Karpman D. Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor. Front Cell Infect Microbiol 2020;10:212. [PMID: 32523894 DOI: 10.3389/fcimb.2020.00212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
61 Brockmeyer J, Aldick T, Soltwisch J, Zhang W, Tarr PI, Weiss A, Dreisewerd K, Müthing J, Bielaszewska M, Karch H. Enterohaemorrhagic Escherichia coli haemolysin is cleaved and inactivated by serine protease EspPα. Environ Microbiol 2011;13:1327-41. [PMID: 21352460 DOI: 10.1111/j.1462-2920.2011.02431.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
62 Yin X, Chambers JR, Wheatcroft R, Johnson RP, Zhu J, Liu B, Gyles CL. Adherence of Escherichia coli O157:H7 mutants in vitro and in ligated pig intestines. Appl Environ Microbiol 2009;75:4975-83. [PMID: 19525268 DOI: 10.1128/AEM.00297-09] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
63 Löfling JC, Paton AW, Varki NM, Paton JC, Varki A. A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome. Kidney Int 2009;76:140-4. [PMID: 19387473 DOI: 10.1038/ki.2009.131] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
64 Tozzoli R, Caprioli A, Cappannella S, Michelacci V, Marziano ML, Morabito S. Production of the subtilase AB5 cytotoxin by Shiga toxin-negative Escherichia coli. J Clin Microbiol 2010;48:178-83. [PMID: 19940059 DOI: 10.1128/JCM.01648-09] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
65 Hua Y, Wu J, Fu M, Liu J, Li X, Zhang B, Zhao W, Wan C. Enterohemorrhagic Escherichia coli Effector Protein EspF Interacts With Host Protein ANXA6 and Triggers Myosin Light Chain Kinase (MLCK)-Dependent Tight Junction Dysregulation. Front Cell Dev Biol 2020;8:613061. [PMID: 33425920 DOI: 10.3389/fcell.2020.613061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Brigotti M, Arfilli V, Carnicelli D, Ricci F, Tazzari PL, Ardissino G, Scavia G, Morabito S, He X. Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component. Toxins (Basel) 2018;10:E379. [PMID: 30231570 DOI: 10.3390/toxins10090379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
67 Oh G, Lau KK. Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center. Int Urol Nephrol 2012;44:1467-72. [PMID: 22116676 DOI: 10.1007/s11255-011-0083-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
68 Binks S, Regan K, Richenberg J, Chevassut T. Microbes without frontiers: severe haemolytic-uraemic syndrome due to E coli O104:H4. BMJ Case Rep 2012;2012:bcr2012006896. [PMID: 23264269 DOI: 10.1136/bcr-2012-006896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
69 Shaaban S, Cowley LA, McAteer SP, Jenkins C, Dallman TJ, Bono JL, Gally DL. Evolution of a zoonotic pathogen: investigating prophage diversity in enterohaemorrhagic Escherichia coli O157 by long-read sequencing. Microb Genom 2016;2:e000096. [PMID: 28348836 DOI: 10.1099/mgen.0.000096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
70 Tseng M, Fratamico PM, Manning SD, Funk JA. Shiga toxin-producing Escherichia coli in swine: the public health perspective. Anim Health Res Rev 2014;15:63-75. [PMID: 24397985 DOI: 10.1017/S1466252313000170] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 4.9] [Reference Citation Analysis]
71 Graves NS. Acute gastroenteritis. Prim Care 2013;40:727-41. [PMID: 23958366 DOI: 10.1016/j.pop.2013.05.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
72 Trachtman H. HUS and TTP in Children. Pediatr Clin North Am 2013;60:1513-26. [PMID: 24237985 DOI: 10.1016/j.pcl.2013.08.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
73 Etcheverría AI, Arroyo GH, Alzola R, Parma AE. Reduction of Adherence of E. coli O157:H7 to HEp-2 Cells and to Bovine Large Intestinal Mucosal Explants by Colicinogenic E. coli. ISRN Microbiol 2011;2011:697020. [PMID: 23724308 DOI: 10.5402/2011/697020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
74 Pacheco AR, Sperandio V. Enteric Pathogens Exploit the Microbiota-generated Nutritional Environment of the Gut. Microbiol Spectr 2015;3. [PMID: 26185079 DOI: 10.1128/microbiolspec.MBP-0001-2014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
75 Watanabe-Takahashi M, Tamada M, Senda M, Hibino M, Shimizu E, Okuta A, Miyazawa A, Senda T, Nishikawa K. Identification of a peptide motif that potently inhibits two functionally distinct subunits of Shiga toxin. Commun Biol 2021;4:538. [PMID: 33972673 DOI: 10.1038/s42003-021-02068-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 De Rauw K, Detemmerman L, Breynaert J, Piérard D. Detection of Shiga toxin-producing and other diarrheagenic Escherichia coli by the BioFire FilmArray® Gastrointestinal Panel in human fecal samples. Eur J Clin Microbiol Infect Dis 2016;35:1479-86. [PMID: 27259710 DOI: 10.1007/s10096-016-2688-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
77 Brocklebank V, Wong EK, Fielding R, Goodship TH, Kavanagh D. Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri.. Clin Kidney J 2014;7:286-8. [PMID: 24944786 DOI: 10.1093/ckj/sfu032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
78 Bonanno L, Petit MA, Loukiadis E, Michel V, Auvray F. Heterogeneity in Induction Level, Infection Ability, and Morphology of Shiga Toxin-Encoding Phages (Stx Phages) from Dairy and Human Shiga Toxin-Producing Escherichia coli O26:H11 Isolates. Appl Environ Microbiol 2016;82:2177-86. [PMID: 26826235 DOI: 10.1128/AEM.03463-15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
79 Costin M, Cinteza E, Balgradean M. Hemolytic Uremic Syndrome - Case report. Maedica (Bucur) 2019;14:298-300. [PMID: 31798749 DOI: 10.26574/maedica.2019.14.3.298] [Reference Citation Analysis]
80 Orth D, Ehrlenbach S, Brockmeyer J, Khan AB, Huber G, Karch H, Sarg B, Lindner H, Würzner R. EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5. Infect Immun 2010;78:4294-301. [PMID: 20643852 DOI: 10.1128/IAI.00488-10] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
81 Vanaja SK, Springman AC, Besser TE, Whittam TS, Manning SD. Differential expression of virulence and stress fitness genes between Escherichia coli O157:H7 strains with clinical or bovine-biased genotypes. Appl Environ Microbiol 2010;76:60-8. [PMID: 19880650 DOI: 10.1128/AEM.01666-09] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
82 Vally H, Hall G, Dyda A, Raupach J, Knope K, Combs B, Desmarchelier P. Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010. BMC Public Health 2012;12:63. [PMID: 22264221 DOI: 10.1186/1471-2458-12-63] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
83 Iguchi A, Nishii H, Seto K, Mitobe J, Lee K, Konishi N, Obata H, Kikuchi T, Iyoda S. Additional Og-Typing PCR Techniques Targeting Escherichia coli-Novel and Shigella-Unique O-Antigen Biosynthesis Gene Clusters. J Clin Microbiol 2020;58:e01493-20. [PMID: 32817086 DOI: 10.1128/JCM.01493-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Toshima H, Yoshimura A, Arikawa K, Hidaka A, Ogasawara J, Hase A, Masaki H, Nishikawa Y. Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins. Appl Environ Microbiol 2007;73:7582-8. [PMID: 17933918 DOI: 10.1128/AEM.01326-07] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
85 Jandhyala DM, Vanguri V, Boll EJ, Lai Y, McCormick BA, Leong JM. Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence. Infect Dis Clin North Am 2013;27:631-49. [PMID: 24011834 DOI: 10.1016/j.idc.2013.05.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
86 Fang Y, Mercer RG, McMullen LM, Gänzle MG. Induction of Shiga Toxin-Encoding Prophage by Abiotic Environmental Stress in Food. Appl Environ Microbiol 2017;83:e01378-17. [PMID: 28778890 DOI: 10.1128/AEM.01378-17] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
87 Fu M, Liang S, Wu J, Hua Y, Chen H, Zhang Z, Liu J, Li X, Zhang B, Zhao W, Wan C. An Escherichia coli Effector Protein EspF May Induce Host DNA Damage via Interaction With SMC1. Front Microbiol 2021;12:682064. [PMID: 34122393 DOI: 10.3389/fmicb.2021.682064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Usein CR, Ciontea AS, Militaru CM, Condei M, Dinu S, Oprea M, Cristea D, Michelacci V, Scavia G, Zota LC, Zaharia A, Morabito S. Molecular characterisation of human Shiga toxin-producing Escherichia coli O26 strains: results of an outbreak investigation, Romania, February to August 2016. Euro Surveill 2017;22. [PMID: 29183554 DOI: 10.2807/1560-7917.ES.2017.22.47.17-00148] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
89 Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012;8:622-33. [PMID: 22986360 DOI: 10.1038/nrneph.2012.195] [Cited by in Crossref: 247] [Cited by in F6Publishing: 218] [Article Influence: 24.7] [Reference Citation Analysis]
90 Akiyoshi DE, Sheoran AS, Rich CM, Richard L, Chapman-Bonofiglio S, Tzipori S. Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2. Infect Immun 2010;78:1376-82. [PMID: 20086088 DOI: 10.1128/IAI.00867-09] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
91 Russo LM, Melton-Celsa AR, O'Brien AD. Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a. J Infect Dis 2016;213:1271-9. [PMID: 26743841 DOI: 10.1093/infdis/jiv557] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
92 Woo da E, Lee JM, Kim YK, Park YH. Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome. Korean J Pediatr 2016;59:100-3. [PMID: 26958070 DOI: 10.3345/kjp.2016.59.2.100] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
93 Locking ME, Pollock KG, Allison LJ, Rae L, Hanson MF, Cowden JM. Escherichia coli O157 infection and secondary spread, Scotland, 1999-2008. Emerg Infect Dis 2011;17:524-7. [PMID: 21392450 DOI: 10.3201/eid1703.100167] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
94 Brocklebank V, Kavanagh D. Protecting the kidney from complement: atypical haemolytic uraemic syndrome. Clin Med (Lond) 2014;14 Suppl 6:s89-94. [PMID: 25468928 DOI: 10.7861/clinmedicine.14-6-s89] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Bai X, Mernelius S, Jernberg C, Einemo IM, Monecke S, Ehricht R, Löfgren S, Matussek A. Shiga Toxin-Producing Escherichia coli Infection in Jönköping County, Sweden: Occurrence and Molecular Characteristics in Correlation With Clinical Symptoms and Duration of stx Shedding. Front Cell Infect Microbiol 2018;8:125. [PMID: 29765909 DOI: 10.3389/fcimb.2018.00125] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
96 Garcia-Castillo MD, Tran T, Bobard A, Renard HF, Rathjen SJ, Dransart E, Stechmann B, Lamaze C, Lord M, Cintrat JC, Enninga J, Tartour E, Johannes L. Retrograde transport is not required for cytosolic translocation of the B-subunit of Shiga toxin. J Cell Sci 2015;128:2373-87. [PMID: 25977475 DOI: 10.1242/jcs.169383] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
97 Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543-547. [PMID: 21270894 DOI: 10.1038/nature09646] [Cited by in Crossref: 1210] [Cited by in F6Publishing: 1105] [Article Influence: 110.0] [Reference Citation Analysis]
98 Zhang W, Bielaszewska M, Kunsmann L, Mellmann A, Bauwens A, Köck R, Kossow A, Anders A, Gatermann S, Karch H. Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans. PLoS One 2013;8:e66717. [PMID: 23805269 DOI: 10.1371/journal.pone.0066717] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
99 Afshar-Kharghan V. Atypical hemolytic uremic syndrome. Hematology Am Soc Hematol Educ Program 2016;2016:217-25. [PMID: 27913483 DOI: 10.1182/asheducation-2016.1.217] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
100 Abu-Ali GS, Ouellette LM, Henderson ST, Whittam TS, Manning SD. Differences in adherence and virulence gene expression between two outbreak strains of enterohaemorrhagic Escherichia coli O157 : H7. Microbiology (Reading) 2010;156:408-19. [PMID: 19892762 DOI: 10.1099/mic.0.033126-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
101 Bielaszewska M, Rüter C, Kunsmann L, Greune L, Bauwens A, Zhang W, Kuczius T, Kim KS, Mellmann A, Schmidt MA, Karch H. Enterohemorrhagic Escherichia coli hemolysin employs outer membrane vesicles to target mitochondria and cause endothelial and epithelial apoptosis. PLoS Pathog 2013;9:e1003797. [PMID: 24348251 DOI: 10.1371/journal.ppat.1003797] [Cited by in Crossref: 96] [Cited by in F6Publishing: 89] [Article Influence: 10.7] [Reference Citation Analysis]
102 Moxley RA, Smith DR. Attaching-effacing Escherichia coli infections in cattle. Vet Clin North Am Food Anim Pract 2010;26:29-56, table of contents. [PMID: 20117541 DOI: 10.1016/j.cvfa.2009.10.011] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
103 Humphries RM, Linscott AJ. Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis. Clin Microbiol Rev 2015;28:3-31. [PMID: 25567220 DOI: 10.1128/CMR.00073-14] [Cited by in Crossref: 91] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
104 Zhang B, Sun X, Fan H, He K, Zhang X. The Fimbrial Gene z3276 in Enterohemorrhagic Escherichia coli O157:H7 Contributes to Bacterial Pathogenicity. Front Microbiol 2018;9:1628. [PMID: 30072979 DOI: 10.3389/fmicb.2018.01628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Connolly JP, Roe AJ. Intracellular d-Serine Accumulation Promotes Genetic Diversity via Modulated Induction of RecA in Enterohemorrhagic Escherichia coli. J Bacteriol 2016;198:3318-28. [PMID: 27698085 DOI: 10.1128/JB.00548-16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Feitz WJC, van Setten PA, van der Velden TJAM, Licht C, van den Heuvel LPJW, van de Kar NCAJ. Cell Biological Responses after Shiga Toxin-1 Exposure to Primary Human Glomerular Microvascular Endothelial Cells from Pediatric and Adult Origin. Int J Mol Sci 2021;22:5615. [PMID: 34070679 DOI: 10.3390/ijms22115615] [Reference Citation Analysis]
107 Harwood R, Wilkinson D, Ramkumar S, Humphrey G. Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome? Pediatr Surg Int 2016;32:235-8. [PMID: 26578260 DOI: 10.1007/s00383-015-3833-6] [Reference Citation Analysis]
108 Forrester A, Rathjen SJ, Daniela Garcia-Castillo M, Bachert C, Couhert A, Tepshi L, Pichard S, Martinez J, Munier M, Sierocki R, Renard HF, Augusto Valades-Cruz C, Dingli F, Loew D, Lamaze C, Cintrat JC, Linstedt AD, Gillet D, Barbier J, Johannes L. Functional dissection of the retrograde Shiga toxin trafficking inhibitor Retro-2. Nat Chem Biol 2020;16:327-36. [PMID: 32080624 DOI: 10.1038/s41589-020-0474-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
109 Baker DR, Moxley RA, Steele MB, Lejeune JT, Christopher-Hennings J, Chen DG, Hardwidge PR, Francis DH. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle. Appl Environ Microbiol 2007;73:7338-46. [PMID: 17890332 DOI: 10.1128/AEM.00755-07] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
110 Momtaz H, Dehkordi FS, Hosseini MJ, Sarshar M, Heidari M. Serogroups, virulence genes and antibiotic resistance in Shiga toxin-producing Escherichia coli isolated from diarrheic and non-diarrheic pediatric patients in Iran. Gut Pathog 2013;5:39. [PMID: 24330673 DOI: 10.1186/1757-4749-5-39] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
111 Chen W, Zuo H, Mahony TJ, Zhang B, Rolfe B, Xu ZP. Efficient induction of comprehensive immune responses to control pathogenic E. coli by clay nano-adjuvant with the moderate size and surface charge. Sci Rep 2017;7:13367. [PMID: 29042573 DOI: 10.1038/s41598-017-13570-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
112 Ritchie JM, Greenwich JL, Davis BM, Bronson RT, Gebhart D, Williams SR, Martin D, Scholl D, Waldor MK. An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease. Antimicrob Agents Chemother 2011;55:5469-74. [PMID: 21947394 DOI: 10.1128/AAC.05031-11] [Cited by in Crossref: 46] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
113 Pradhan S, Karve SS, Weiss AA, Hawkins J, Poling HM, Helmrath MA, Wells JM, McCauley HA. Tissue Responses to Shiga Toxin in Human Intestinal Organoids. Cell Mol Gastroenterol Hepatol 2020;10:171-90. [PMID: 32145469 DOI: 10.1016/j.jcmgh.2020.02.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
114 Melli LJ, Zylberman V, Hiriart Y, Lauche CE, Baschkier A, Pardo R, Miliwebsky E, Chinen I, Rivas M, Goldbaum FA, Ugalde JE, Comerci DJ, Ciocchini AE. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples. J Clin Microbiol 2020;58:e01566-19. [PMID: 31826960 DOI: 10.1128/JCM.01566-19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Launders N, Byrne L, Jenkins C, Harker K, Charlett A, Adak GK. Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012. BMJ Open 2016;6:e009933. [PMID: 26826153 DOI: 10.1136/bmjopen-2015-009933] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
116 Kailasan Vanaja S, Bergholz TM, Whittam TS. Characterization of the Escherichia coli O157:H7 Sakai GadE regulon. J Bacteriol 2009;191:1868-77. [PMID: 19114477 DOI: 10.1128/JB.01481-08] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
117 Berger M, Aijaz I, Berger P, Dobrindt U, Koudelka G. Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli. Sci Rep 2019;9:18777. [PMID: 31827185 DOI: 10.1038/s41598-019-55332-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
118 Sursal T, Stearns-Kurosawa DJ, Itagaki K, Oh SY, Sun S, Kurosawa S, Hauser CJ. Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates. Shock. 2013;39:55-62. [PMID: 23247122 DOI: 10.1097/shk.0b013e318276f4ca] [Cited by in Crossref: 22] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
119 Leyva-Illades D, Cherla RP, Galindo CL, Chopra AK, Tesh VL. Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1. Infect Immun 2010;78:2454-65. [PMID: 20351145 DOI: 10.1128/IAI.01341-09] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
120 Li T, Tu W, Liu Y, Zhou P, Cai K, Li Z, Liu X, Ning N, Huang J, Wang S, Huang J, Wang H. A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo. Sci Rep 2016;6:21837. [PMID: 26903273 DOI: 10.1038/srep21837] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
121 Brockmeyer J, Spelten S, Kuczius T, Bielaszewska M, Karch H. Structure and function relationship of the autotransport and proteolytic activity of EspP from Shiga toxin-producing Escherichia coli. PLoS One 2009;4:e6100. [PMID: 19568421 DOI: 10.1371/journal.pone.0006100] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
122 Uhlich GA, Reichenberger ER, Cottrell BJ, Fratamico P, Andreozzi E. Whole-Genome Sequence of Escherichia coli Serotype O157:H7 Strain B6914-ARS. Genome Announc 2017;5:e01191-17. [PMID: 29097463 DOI: 10.1128/genomeA.01191-17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
123 In J, Lukyanenko V, Foulke-Abel J, Hubbard AL, Delannoy M, Hansen AM, Kaper JB, Boisen N, Nataro JP, Zhu C, Boedeker EC, Girón JA, Kovbasnjuk O. Serine protease EspP from enterohemorrhagic Escherichia coli is sufficient to induce shiga toxin macropinocytosis in intestinal epithelium. PLoS One 2013;8:e69196. [PMID: 23874912 DOI: 10.1371/journal.pone.0069196] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
124 Bruyand M, Mariani-Kurkdjian P, Le Hello S, King LA, Van Cauteren D, Lefevre S, Gouali M, Jourdan-da Silva N, Mailles A, Donguy MP, Loukiadis E, Sergentet-Thevenot D, Loirat C, Bonacorsi S, Weill FX, De Valk H; Réseau Français Hospitalier de Surveillance du Shu Pédiatrique. Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016. Euro Surveill 2019;24. [PMID: 30808442 DOI: 10.2807/1560-7917.ES.2019.24.8.1800068] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 9.5] [Reference Citation Analysis]
125 Law RJ, Gur-Arie L, Rosenshine I, Finlay BB. In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections. Cold Spring Harb Perspect Med 2013;3:a009977. [PMID: 23457294 DOI: 10.1101/cshperspect.a009977] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
126 Hirata C, Kenzaka T, Akita H. Late onset of hemolytic uremic syndrome after the appearance of prodromal gastrointestinal tract symptoms. Clin Case Rep 2020;8:1910-3. [PMID: 33088517 DOI: 10.1002/ccr3.3020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Park JY, Jeong YJ, Park SK, Yoon SJ, Choi S, Jeong DG, Chung SW, Lee BJ, Kim JH, Tesh VL, Lee MS, Park YJ. Shiga Toxins Induce Apoptosis and ER Stress in Human Retinal Pigment Epithelial Cells. Toxins (Basel) 2017;9:E319. [PMID: 29027919 DOI: 10.3390/toxins9100319] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
128 Radhakrishnan ST, Ruban A, Uthayakumar AK, Cohen P, Levy J, Teare J. Haemolytic uraemic syndrome - a rare case report of bloody diarrhoea in adults. BMC Gastroenterol 2019;19:156. [PMID: 31462210 DOI: 10.1186/s12876-019-1071-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Hatchette TF, Farina D. Infectious diarrhea: when to test and when to treat. CMAJ 2011;183:339-44. [PMID: 21173060 DOI: 10.1503/cmaj.091495] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
130 Kim JS, Lee MS, Kim JH. Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs. Front Cell Infect Microbiol 2020;10:273. [PMID: 32582571 DOI: 10.3389/fcimb.2020.00273] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
131 Loos S, Oh J, van de Loo L, Kemper MJ, Blohm M, Schild R. Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS). Pediatr Nephrol 2021. [PMID: 34046736 DOI: 10.1007/s00467-021-05108-6] [Reference Citation Analysis]
132 Amézquita-López BA, Quiñones B, Lee BG, Chaidez C. Virulence profiling of Shiga toxin-producing Escherichia coli recovered from domestic farm animals in Northwestern Mexico. Front Cell Infect Microbiol 2014;4:7. [PMID: 24551599 DOI: 10.3389/fcimb.2014.00007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
133 Sonntag AK, Bielaszewska M, Mellmann A, Dierksen N, Schierack P, Wieler LH, Schmidt MA, Karch H. Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl Environ Microbiol 2005;71:8855-63. [PMID: 16332882 DOI: 10.1128/AEM.71.12.8855-8863.2005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
134 Ståhl AL, Sartz L, Nelsson A, Békássy ZD, Karpman D. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 2009;4:e6990. [PMID: 19750223 DOI: 10.1371/journal.pone.0006990] [Cited by in F6Publishing: 83] [Reference Citation Analysis]
135 Salvadori M, Bertoni E. Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations. World J Nephrol 2013; 2(3): 56-76 [PMID: 24255888 DOI: 10.5527/wjn.v2.i3.56] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
136 Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B, Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP, Menne TF, Meyer TN, Michael C, Münte T, Neumann-Grutzeck C, Nuernberger J, Pavenstaedt H, Ramazan L, Renders L, Repenthin J, Ries W, Rohr A, Rump LC, Samuelsson O, Sayk F, Schmidt BM, Schnatter S, Schöcklmann H, Schreiber S, von Seydewitz CU, Steinhoff J, Stracke S, Suerbaum S, van de Loo A, Vischedyk M, Weissenborn K, Wellhöner P, Wiesner M, Zeissig S, Büning J, Schiffer M, Kuehbacher T; EHEC-HUS consortium. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012;345:e4565. [PMID: 22815429 DOI: 10.1136/bmj.e4565] [Cited by in Crossref: 203] [Cited by in F6Publishing: 164] [Article Influence: 20.3] [Reference Citation Analysis]
137 Mahan MJ, Kubicek-Sutherland JZ, Heithoff DM. Rise of the microbes. Virulence 2013;4:213-22. [PMID: 23334178 DOI: 10.4161/viru.23380] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
138 Greig DR, Mikhail AFW, Dallman TJ, Jenkins C. Analysis Shiga Toxin-Encoding Bacteriophage in a Rare Strain of Shiga Toxin-Producing Escherichia coli O157:H7 stx2a/stx2c. Front Microbiol 2020;11:577658. [PMID: 33193199 DOI: 10.3389/fmicb.2020.577658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
139 Johura FT, Parveen R, Islam A, Sadique A, Rahim MN, Monira S, Khan AR, Ahsan S, Ohnishi M, Watanabe H, Chakraborty S, George CM, Cravioto A, Navarro A, Hasan B, Alam M. Occurrence of Hybrid Escherichia coli Strains Carrying Shiga Toxin and Heat-Stable Toxin in Livestock of Bangladesh. Front Public Health 2016;4:287. [PMID: 28119905 DOI: 10.3389/fpubh.2016.00287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
140 Nawrocki EM, Mosso HM, Dudley EG. A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression. Appl Environ Microbiol 2020;86:e00509-20. [PMID: 32358004 DOI: 10.1128/AEM.00509-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. Int J Hematol 2014;100:437-42. [PMID: 25135378 DOI: 10.1007/s12185-014-1655-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
142 Liu Z, Man SM, Zhu Q, Vogel P, Frase S, Fukui Y, Kanneganti TD. DOCK2 confers immunity and intestinal colonization resistance to Citrobacter rodentium infection. Sci Rep 2016;6:27814. [PMID: 27291827 DOI: 10.1038/srep27814] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
143 Lee KS, Jeong YJ, Lee MS. Escherichia coli Shiga Toxins and Gut Microbiota Interactions. Toxins (Basel) 2021;13:416. [PMID: 34208170 DOI: 10.3390/toxins13060416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 de Souza RL, Abreu Carvalhaes JT, Sanae Nishimura L, de Andrade MC, Cabilio Guth BE. Hemolytic uremic syndrome in pediatric intensive care units in são paulo, Brazil. Open Microbiol J 2011;5:76-82. [PMID: 21804902 DOI: 10.2174/1874285801105010076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
145 Lee JH, Kim YG, Cho MH, Wood TK, Lee J. Transcriptomic analysis for genetic mechanisms of the factors related to biofilm formation in Escherichia coli O157:H7. Curr Microbiol 2011;62:1321-30. [PMID: 21221972 DOI: 10.1007/s00284-010-9862-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
146 Johannes L. Shiga Toxin-A Model for Glycolipid-Dependent and Lectin-Driven Endocytosis. Toxins (Basel) 2017;9:E340. [PMID: 29068384 DOI: 10.3390/toxins9110340] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
147 Dehkordi FS, Yazdani F, Mozafari J, Valizadeh Y. Virulence factors, serogroups and antimicrobial resistance properties of Escherichia coli strains in fermented dairy products. BMC Res Notes 2014;7:217. [PMID: 24708594 DOI: 10.1186/1756-0500-7-217] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
148 Hazen TH, Michalski J, Luo Q, Shetty AC, Daugherty SC, Fleckenstein JM, Rasko DA. Comparative genomics and transcriptomics of Escherichia coli isolates carrying virulence factors of both enteropathogenic and enterotoxigenic E. coli. Sci Rep 2017;7:3513. [PMID: 28615618 DOI: 10.1038/s41598-017-03489-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
149 Brocklebank V, Wood KM, Kavanagh D. Thrombotic Microangiopathy and the Kidney. Clin J Am Soc Nephrol. 2018;13:300-317. [PMID: 29042465 DOI: 10.2215/cjn.00620117] [Cited by in Crossref: 103] [Cited by in F6Publishing: 57] [Article Influence: 20.6] [Reference Citation Analysis]
150 Buvens G, De Rauw K, Roisin S, Vanfraechem G, Denis O, Jacobs F, Scheutz F, Piérard D. Verocytotoxin-producing Escherichia coli O128ab:H2 bacteremia in a 27-year-old male with hemolytic-uremic syndrome. J Clin Microbiol 2013;51:1633-5. [PMID: 23467596 DOI: 10.1128/JCM.03025-12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
151 Bauer A, Loos S, Wehrmann C, Horstmann D, Donnerstag F, Lemke J, Hillebrand G, Löbel U, Pape L, Haffner D, Bindt C, Ahlenstiel T, Melk A, Lehnhardt A, Kemper MJ, Oh J, Hartmann H. Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol 2014;29:1607-15. [PMID: 24664191 DOI: 10.1007/s00467-014-2803-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
152 Wahl E, Vold L, Lindstedt BA, Bruheim T, Afset JE. Investigation of an Escherichia coli O145 outbreak in a child day-care centre--extensive sampling and characterization of eae- and stx1-positive E. coli yields epidemiological and socioeconomic insight. BMC Infect Dis 2011;11:238. [PMID: 21902833 DOI: 10.1186/1471-2334-11-238] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
153 Kavanagh D, Raman S, Sheerin NS. Management of hemolytic uremic syndrome. F1000Prime Rep 2014;6:119. [PMID: 25580273 DOI: 10.12703/P6-119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
154 Jamme M, Raimbourg Q, Chauveau D, Seguin A, Presne C, Perez P, Gobert P, Wynckel A, Provôt F, Delmas Y, Mousson C, Servais A, Vrigneaud L, Veyradier A, Rondeau E, Coppo P; French Thrombotic Microangiopathies Reference Centre. Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome. PLoS One 2017;12:e0177894. [PMID: 28542627 DOI: 10.1371/journal.pone.0177894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
155 Allen KJ, Laing CR, Cancarevic A, Zhang Y, Mesak LR, Xu H, Paccagnella A, Gannon VP, Hoang L. Characteristics of clinical Shiga toxin-producing Escherichia coli isolated from British Columbia. Biomed Res Int 2013;2013:878956. [PMID: 24199201 DOI: 10.1155/2013/878956] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
156 Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 2009;77:959-69. [PMID: 19124603 DOI: 10.1128/IAI.00679-08] [Cited by in Crossref: 57] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
157 Lund BM, O'Brien SJ. The occurrence and prevention of foodborne disease in vulnerable people. Foodborne Pathog Dis 2011;8:961-73. [PMID: 21561383 DOI: 10.1089/fpd.2011.0860] [Cited by in Crossref: 114] [Cited by in F6Publishing: 81] [Article Influence: 10.4] [Reference Citation Analysis]
158 Myrnäs A, Castegren M. Fatal hemolytic uremic syndrome associated with day care surgery and anaesthesia: a case report. BMC Res Notes 2013;6:242. [PMID: 23803463 DOI: 10.1186/1756-0500-6-242] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
159 Parma YR, Chacana PA, Lucchesi PM, Rogé A, Granobles Velandia CV, Krüger A, Parma AE, Fernández-Miyakawa ME. Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies. Front Cell Infect Microbiol 2012;2:84. [PMID: 22919675 DOI: 10.3389/fcimb.2012.00084] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
160 Collins JW, Akin AR, Kosta A, Zhang N, Tangney M, Francis KP, Frankel G. Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity. Microbiology (Reading) 2012;158:2826-34. [PMID: 22902730 DOI: 10.1099/mic.0.060830-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
161 Russo LM, Abdeltawab NF, O'Brien AD, Kotb M, Melton-Celsa AR. Mapping of genetic loci that modulate differential colonization by Escherichia coli O157:H7 TUV86-2 in advanced recombinant inbred BXD mice. BMC Genomics 2015;16:947. [PMID: 26573818 DOI: 10.1186/s12864-015-2127-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
162 Zhang W, Bielaszewska M, Pulz M, Becker K, Friedrich AW, Karch H, Kuczius T. New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants. J Clin Microbiol 2008;46:1292-7. [PMID: 18272709 DOI: 10.1128/JCM.02271-07] [Cited by in Crossref: 63] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
163 Jia B, Li X, Liu W, Lu C, Lu X, Ma L, Li YY, Wei C. GLAPD: Whole Genome Based LAMP Primer Design for a Set of Target Genomes. Front Microbiol 2019;10:2860. [PMID: 31921040 DOI: 10.3389/fmicb.2019.02860] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
164 Lai Y, Riley K, Cai A, Leong JM, Herman IM. Calpain mediates epithelial cell microvillar effacement by enterohemorrhagic Escherichia coli. Front Microbiol 2011;2:222. [PMID: 22073041 DOI: 10.3389/fmicb.2011.00222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
165 Thomassin JL, Lee MJ, Brannon JR, Sheppard DC, Gruenheid S, Le Moual H. Both group 4 capsule and lipopolysaccharide O-antigen contribute to enteropathogenic Escherichia coli resistance to human α-defensin 5. PLoS One 2013;8:e82475. [PMID: 24324796 DOI: 10.1371/journal.pone.0082475] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
166 Quirós P, Martínez-Castillo A, Muniesa M. Improving detection of Shiga toxin-producing Escherichia coli by molecular methods by reducing the interference of free Shiga toxin-encoding bacteriophages. Appl Environ Microbiol 2015;81:415-21. [PMID: 25362055 DOI: 10.1128/AEM.02941-14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
167 Xicohtencatl-Cortes J, Monteiro-Neto V, Ledesma MA, Jordan DM, Francetic O, Kaper JB, Puente JL, Girón JA. Intestinal adherence associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J Clin Invest 2007;117:3519-29. [PMID: 17948128 DOI: 10.1172/JCI30727] [Cited by in Crossref: 100] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
168 Sargeant JM, Majowicz SE, Snelgrove J. The burden of acute gastrointestinal illness in Ontario, Canada, 2005-2006. Epidemiol Infect 2008;136:451-60. [PMID: 17565767 DOI: 10.1017/S0950268807008837] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
169 Merkel V, Ohder B, Bielaszewska M, Zhang W, Fruth A, Menge C, Borrmann E, Middendorf B, Müthing J, Karch H, Mellmann A. Distribution and phylogeny of immunoglobulin-binding protein G in Shiga toxin-producing Escherichia coli and its association with adherence phenotypes. Infect Immun 2010;78:3625-36. [PMID: 20547747 DOI: 10.1128/IAI.00006-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
170 Rocchetti L, Munari B, Varrone E, Porcellini E, Orth-Höller D, Würzner R, Carnicelli D, Brigotti M. Method for the Detection of the Cleaved Form of Shiga Toxin 2a Added to Normal Human Serum. Toxins (Basel) 2021;13:94. [PMID: 33530614 DOI: 10.3390/toxins13020094] [Reference Citation Analysis]
171 Wei X, Zhang L, Zhang R, Koci M, Si D, Ahmad B, Cheng J, Wang J, Aihemaiti M, Zhang M. A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions. Front Immunol 2020;11:1361. [PMID: 32695115 DOI: 10.3389/fimmu.2020.01361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Hazen TH, Daugherty SC, Shetty AC, Nataro JP, Rasko DA. Transcriptional Variation of Diverse Enteropathogenic Escherichia coli Isolates under Virulence-Inducing Conditions. mSystems 2017;2:e00024-17. [PMID: 28766584 DOI: 10.1128/mSystems.00024-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
173 Worley JN, Flores KA, Yang X, Chase JA, Cao G, Tang S, Meng J, Atwill ER. Prevalence and Genomic Characterization of Escherichia coli O157:H7 in Cow-Calf Herds throughout California. Appl Environ Microbiol 2017;83:e00734-17. [PMID: 28550057 DOI: 10.1128/AEM.00734-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
174 Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, Lee J. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun 2011;79:4819-27. [PMID: 21930760 DOI: 10.1128/IAI.05580-11] [Cited by in Crossref: 113] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
175 Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ 2017;189:E153-9. [PMID: 27754896 DOI: 10.1503/cmaj.160142] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
176 Russo LM, Melton-Celsa AR, Smith MA, Smith MJ, O'Brien AD. Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10. Infect Immun 2014;82:1213-21. [PMID: 24379294 DOI: 10.1128/IAI.01264-13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
177 Adams NL, Byrne L, Rose TC, Adak GK, Jenkins C, Charlett A, Violato M, O'Brien SJ, Whitehead MM, Barr B, Taylor-Robinson DC, Hawker JI. Influence of socio-economic status on Shiga toxin-producing Escherichia coli (STEC) infection incidence, risk factors and clinical features. Epidemiol Infect 2019;147:e215. [PMID: 31364538 DOI: 10.1017/S0950268819000864] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Wu SY, Park GY, Kim SH, Hulme J, An SS. Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7. Drug Des Devel Ther 2016;10:3363-78. [PMID: 27789937 DOI: 10.2147/DDDT.S114832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Friedrich AW, Lu S, Bielaszewska M, Prager R, Bruns P, Xu JG, Tschäpe H, Karch H. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J Clin Microbiol 2006;44:1844-6. [PMID: 16672418 DOI: 10.1128/JCM.44.5.1844-1846.2006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
180 Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol 2014;36:399-420. [PMID: 24526222 DOI: 10.1007/s00281-014-0416-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 67] [Article Influence: 11.5] [Reference Citation Analysis]
181 Xavier RN, Morgan HW, McDonald IR, Withers H. Effect of long-term starvation on the survival, recovery, and carbon utilization profiles of a bovine Escherichia coli O157:H7 isolate from New Zealand. Appl Environ Microbiol 2014;80:4383-90. [PMID: 24814789 DOI: 10.1128/AEM.00045-14] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
182 Ooka T, Terajima J, Kusumoto M, Iguchi A, Kurokawa K, Ogura Y, Asadulghani M, Nakayama K, Murase K, Ohnishi M, Iyoda S, Watanabe H, Hayashi T. Development of a multiplex PCR-based rapid typing method for enterohemorrhagic Escherichia coli O157 strains. J Clin Microbiol 2009;47:2888-94. [PMID: 19641072 DOI: 10.1128/JCM.00792-09] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
183 Tran SL, Billoud L, Lewis SB, Phillips AD, Schüller S. Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4. Cell Microbiol 2014;16:1255-66. [PMID: 24612002 DOI: 10.1111/cmi.12281] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
184 Cho SH, Kim JB, Park YB, Park MS, Chae HS, Lee HK. A case of a shiga toxin producing Escherichia coli. Yonsei Med J 2011;52:1039-43. [PMID: 22028174 DOI: 10.3349/ymj.2011.52.6.1039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
185 Yan Y, Shi Y, Cao D, Meng X, Xia L, Sun J. Prevalence of Stx phages in environments of a pig farm and lysogenic infection of the field E. coli O157 isolates with a recombinant converting Phage. Curr Microbiol 2011;62:458-64. [PMID: 20697714 DOI: 10.1007/s00284-010-9729-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
186 Rueter C, Bielaszewska M. Secretion and Delivery of Intestinal Pathogenic Escherichia coli Virulence Factors via Outer Membrane Vesicles. Front Cell Infect Microbiol 2020;10:91. [PMID: 32211344 DOI: 10.3389/fcimb.2020.00091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
187 Silva CJ, Erickson-Beltran ML, Skinner CB, Patfield SA, He X. Mass Spectrometry-Based Method of Detecting and Distinguishing Type 1 and Type 2 Shiga-Like Toxins in Human Serum. Toxins (Basel) 2015;7:5236-53. [PMID: 26633510 DOI: 10.3390/toxins7124875] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
188 Faron ML, Ledeboer NA, Connolly J, Granato PA, Alkins BR, Dien Bard J, Daly JA, Young S, Buchan BW. Clinical Evaluation and Cost Analysis of Great Basin Shiga Toxin Direct Molecular Assay for Detection of Shiga Toxin-Producing Escherichia coli in Diarrheal Stool Specimens. J Clin Microbiol 2017;55:519-25. [PMID: 27927919 DOI: 10.1128/JCM.01939-16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
189 Marejková M, Bláhová K, Janda J, Fruth A, Petráš P. Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic. PLoS One 2013;8:e73927. [PMID: 24040117 DOI: 10.1371/journal.pone.0073927] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
190 Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis. 2012;55:33-41. [PMID: 22431799 DOI: 10.1093/cid/cis299] [Cited by in Crossref: 166] [Cited by in F6Publishing: 140] [Article Influence: 16.6] [Reference Citation Analysis]
191 Betz J, Bielaszewska M, Thies A, Humpf HU, Dreisewerd K, Karch H, Kim KS, Friedrich AW, Müthing J. Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J Lipid Res 2011;52:618-34. [PMID: 21252262 DOI: 10.1194/jlr.M010819] [Cited by in Crossref: 54] [Cited by in F6Publishing: 26] [Article Influence: 4.9] [Reference Citation Analysis]
192 Butt S, Allison L, Vishram B, Greig DR, Aird H, McDonald E, Drennan G, Jenkins C, Byrne L, Licence K, Smith-Palmer A; Incident Management Team. Epidemiological investigations identified an outbreak of Shiga toxin-producing Escherichia coli serotype O26:H11 associated with pre-packed sandwiches. Epidemiol Infect 2021;149:e178. [PMID: 34635196 DOI: 10.1017/S0950268821001576] [Reference Citation Analysis]
193 Gurjar BS, Manikanta Sriharsha T, Bhasym A, Prabhu S, Puraswani M, Khandelwal P, Saini H, Saini S, Verma AK, Chatterjee P, Guchhait P, Bal V, George A, Rath S, Sahu A, Sharma A, Hari P, Sinha A, Bagga A. Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome. Immunology 2018. [PMID: 29485195 DOI: 10.1111/imm.12916] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
194 Costigan C, Raftery T, Carroll AG, Wildes D, Reynolds C, Cunney R, Dolan N, Drew RJ, Lynch BJ, O'Rourke DJ, Stack M, Sweeney C, Shahwan A, Twomey E, Waldron M, Riordan M, Awan A, Gorman KM. Neurological involvement in children with hemolytic uremic syndrome. Eur J Pediatr 2021. [PMID: 34378062 DOI: 10.1007/s00431-021-04200-1] [Reference Citation Analysis]
195 Feitz WJC, van de Kar NCAJ, Cheong I, van der Velden TJAM, Ortiz-Sandoval CG, Orth-Höller D, van den Heuvel LPJW, Licht C. Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells. Toxins (Basel) 2020;12:E483. [PMID: 32751286 DOI: 10.3390/toxins12080483] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Marcon MJ. Point: Should all stools be screened for Shiga toxin-producing Escherichia coli? J Clin Microbiol 2011;49:2390-4. [PMID: 21543568 DOI: 10.1128/JCM.00817-11] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
197 Basu D, Kahn JN, Li XP, Tumer NE. Conserved Arginines at the P-Protein Stalk Binding Site and the Active Site Are Critical for Ribosome Interactions of Shiga Toxins but Do Not Contribute to Differences in the Affinity of the A1 Subunits for the Ribosome. Infect Immun 2016;84:3290-301. [PMID: 27600507 DOI: 10.1128/IAI.00630-16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
198 Geelen J, van den Biggelaar M, Linssen P, van der Velden T, Mertens K, Monnens L. The effect of shiga toxin on weibel-palade bodies in primary human endothelial cells. Nephron Extra 2014;4:101-7. [PMID: 25177338 DOI: 10.1159/000363299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
199 Puño-Sarmiento J, Anderson EM, Park AJ, Khursigara CM, Barnett Foster DE. Potentiation of Antibiotics by a Novel Antimicrobial Peptide against Shiga Toxin Producing E. coli O157:H7. Sci Rep 2020;10:10029. [PMID: 32572054 DOI: 10.1038/s41598-020-66571-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
200 Wang-Lin SX, Balthasar JP. Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections. Antibodies (Basel) 2018;7:E5. [PMID: 31544858 DOI: 10.3390/antib7010005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
201 Gouali M, Ruckly C, Carle I, Lejay-Collin M, Weill FX. Evaluation of CHROMagar STEC and STEC O104 chromogenic agar media for detection of Shiga Toxin-producing Escherichia coli in stool specimens. J Clin Microbiol 2013;51:894-900. [PMID: 23284030 DOI: 10.1128/JCM.03121-12] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
202 Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 2008;14:1287-90. [PMID: 18680658 DOI: 10.3201/eid1408.071082] [Cited by in Crossref: 206] [Cited by in F6Publishing: 177] [Article Influence: 14.7] [Reference Citation Analysis]
203 Berger P, Kouzel IU, Berger M, Haarmann N, Dobrindt U, Koudelka GB, Mellmann A. Carriage of Shiga toxin phage profoundly affects Escherichia coli gene expression and carbon source utilization. BMC Genomics 2019;20:504. [PMID: 31208335 DOI: 10.1186/s12864-019-5892-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
204 Liu Y, Tian S, Thaker H, Dong M. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Toxins (Basel) 2021;13:222. [PMID: 33803852 DOI: 10.3390/toxins13030222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
205 Samadder P, Xicohtencatl-Cortes J, Saldaña Z, Jordan D, Tarr PI, Kaper JB, Girón JA. The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E.  coli O157:H7. Environ Microbiol 2009;11:1815-26. [PMID: 19508558 DOI: 10.1111/j.1462-2920.2009.01906.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
206 Orth D, Grif K, Zimmerhackl LB, Würzner R. Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157 in Austria. Wien Klin Wochenschr 2009;121:108-12. [PMID: 19280135 DOI: 10.1007/s00508-008-1133-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
207 Hazen TH, Sahl JW, Fraser CM, Donnenberg MS, Scheutz F, Rasko DA. Refining the pathovar paradigm via phylogenomics of the attaching and effacing Escherichia coli. Proc Natl Acad Sci U S A 2013;110:12810-5. [PMID: 23858472 DOI: 10.1073/pnas.1306836110] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 9.6] [Reference Citation Analysis]
208 Joseph A, Cointe A, Mariani Kurkdjian P, Rafat C, Hertig A. Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review. Toxins (Basel) 2020;12:E67. [PMID: 31973203 DOI: 10.3390/toxins12020067] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
209 Chokoshvili O, Lomashvili K, Malakmadze N, Geleishvil M, Brant J, Imnadze P, Chitadze N, Tevzadze L, Chanturia G, Tevdoradze T, Tsertsvadze T, Talkington D, Mody RK, Strockbine N, Gerber RA, Maes E, Rush T. Investigation of an outbreak of bloody diarrhea complicated with hemolytic uremic syndrome. J Epidemiol Glob Health 2014;4:249-59. [PMID: 25455642 DOI: 10.1016/j.jegh.2014.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
210 Matussek A, Einemo IM, Jogenfors A, Löfdahl S, Löfgren S. Shiga Toxin-Producing Escherichia coli in Diarrheal Stool of Swedish Children: Evaluation of Polymerase Chain Reaction Screening and Duration of Shiga Toxin Shedding. J Pediatric Infect Dis Soc 2016;5:147-51. [PMID: 27199470 DOI: 10.1093/jpids/piv003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
211 Huang J, Motto DG, Bundle DR, Sadler JE. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice. Blood 2010;116:3653-9. [PMID: 20644116 DOI: 10.1182/blood-2010-02-271957] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
212 Obrig TG. Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2010;2:2769-94. [PMID: 21297888 DOI: 10.3390/toxins2122769] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
213 Mitsui T, Watanabe-Takahashi M, Shimizu E, Zhang B, Funamoto S, Yamasaki S, Nishikawa K. Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition. Infect Immun 2016;84:2653-61. [PMID: 27382021 DOI: 10.1128/IAI.00149-16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
214 Engelmann L. [Thrombophilic states in intensive care medicine]. Med Klin Intensivmed Notfmed 2011;106:189-97. [PMID: 22033885 DOI: 10.1007/s00063-011-0015-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
215 Andreozzi E, Uhlich GA. PchE Regulation of Escherichia coli O157:H7 Flagella, Controlling the Transition to Host Cell Attachment. Int J Mol Sci 2020;21:E4592. [PMID: 32605187 DOI: 10.3390/ijms21134592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Sartz L, De Jong B, Hjertqvist M, Plym-Forshell L, Alsterlund R, Löfdahl S, Osterman B, Ståhl A, Eriksson E, Hansson HB, Karpman D. An outbreak of Escherichia coli O157:H7 infection in southern Sweden associated with consumption of fermented sausage; aspects of sausage production that increase the risk of contamination. Epidemiol Infect 2008;136:370-80. [PMID: 17445322 DOI: 10.1017/S0950268807008473] [Cited by in Crossref: 62] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
217 Shima K, Wu Y, Sugimoto N, Asakura M, Nishimura K, Yamasaki S. Comparison of a PCR-restriction fragment length polymorphism (PCR-RFLP) assay to pulsed-field gel electrophoresis to determine the effect of repeated subculture and prolonged storage on RFLP patterns of Shiga toxin-producing Escherichia coli O157:H7. J Clin Microbiol 2006;44:3963-8. [PMID: 16971640 DOI: 10.1128/JCM.00717-06] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
218 Tarr GAM, Stokowski T, Shringi S, Tarr PI, Freedman SB, Oltean HN, Rabinowitz PM, Chui L. Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence. Toxins (Basel) 2019;11:E607. [PMID: 31635282 DOI: 10.3390/toxins11100607] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
219 Cherla RP, Lee SY, Mulder RA, Lee MS, Tesh VL. Shiga toxin 1-induced proinflammatory cytokine production is regulated by the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway. Infect Immun 2009;77:3919-31. [PMID: 19596774 DOI: 10.1128/IAI.00738-09] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
220 Secher T, Shima A, Hinsinger K, Cintrat JC, Johannes L, Barbier J, Gillet D, Oswald E. Retrograde Trafficking Inhibitor of Shiga Toxins Reduces Morbidity and Mortality of Mice Infected with Enterohemorrhagic Escherichia coli. Antimicrob Agents Chemother 2015;59:5010-3. [PMID: 25987610 DOI: 10.1128/AAC.00455-15] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
221 Maginnis P, Anderton J, Nair B, Woywodt A. tHe USual Suspects. NDT Plus 2011;4:260-3. [PMID: 25949498 DOI: 10.1093/ndtplus/sfr031] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
222 Hsu BB, Way JC, Silver PA. Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut. mSystems 2020;5:e00013-20. [PMID: 31992629 DOI: 10.1128/mSystems.00013-20] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
223 Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr 2010;169:7-13. [PMID: 19707787 DOI: 10.1007/s00431-009-1039-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
224 Detzner J, Pohlentz G, Müthing J. Thin-Layer Chromatography in Structure and Recognition Studies of Shiga Toxin Glycosphingolipid Receptors. Methods Mol Biol 2021;2291:229-52. [PMID: 33704756 DOI: 10.1007/978-1-0716-1339-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
225 Brockmeyer J, Bielaszewska M, Fruth A, Bonn ML, Mellmann A, Humpf HU, Karch H. Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl Environ Microbiol 2007;73:6351-9. [PMID: 17704265 DOI: 10.1128/AEM.00920-07] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
226 Engen RM, Killien EY, Davis JL, Symons JM, Hartmann SM. C septicum Complicating Hemolytic Uremic Syndrome: Survival Without Surgical Intervention. Pediatrics 2017;139:e20161362. [PMID: 28183731 DOI: 10.1542/peds.2016-1362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
227 Riquelme-Neira R, Rivera A, Sáez D, Fernández P, Osorio G, del Canto F, Salazar JC, Vidal RM, Oñate A. Vaccination with DNA Encoding Truncated Enterohemorrhagic Escherichia coli (EHEC) Factor for Adherence-1 Gene (efa-1') Confers Protective Immunity to Mice Infected with E. coli O157:H7. Front Cell Infect Microbiol 2015;5:104. [PMID: 26835434 DOI: 10.3389/fcimb.2015.00104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
228 Cho SH, Oh KH, Kim SH, Oh HB, Park MS. Distribution of Virulence Genes and Their Association of Serotypes in Pathogenic Escherichia coli Isolates From Diarrheal Patients in Korea. Osong Public Health Res Perspect 2010;1:29-35. [PMID: 24159437 DOI: 10.1016/j.phrp.2010.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
229 Dallman TJ, Greig DR, Gharbia SE, Jenkins C. Phylogenetic structure of Shiga toxin-producing Escherichia coli O157:H7 from sub-lineage to SNPs. Microb Genom 2021;7. [PMID: 33720818 DOI: 10.1099/mgen.0.000544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Rojas-Lopez M, Monterio R, Pizza M, Desvaux M, Rosini R. Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development. Front Microbiol 2018;9:440. [PMID: 29615989 DOI: 10.3389/fmicb.2018.00440] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
231 Hirakawa H, Suzue K, Takita A, Tomita H. Roles of OmpA in Type III Secretion System-Mediated Virulence of Enterohemorrhagic Escherichia coli. Pathogens 2021;10:1496. [PMID: 34832651 DOI: 10.3390/pathogens10111496] [Reference Citation Analysis]
232 Jandhyala DM, Ahluwalia A, Schimmel JJ, Rogers AB, Leong JM, Thorpe CM. Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation. Infect Immun 2016;84:138-48. [PMID: 26483408 DOI: 10.1128/IAI.00977-15] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
233 Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ, Ingber DE. Microfluidic Organ-on-a-Chip Models of Human Intestine. Cell Mol Gastroenterol Hepatol. 2018;5:659-668. [PMID: 29713674 DOI: 10.1016/j.jcmgh.2017.12.010] [Cited by in Crossref: 218] [Cited by in F6Publishing: 189] [Article Influence: 54.5] [Reference Citation Analysis]
234 Luck SN, Badea L, Bennett-Wood V, Robins-Browne R, Hartland EL. Contribution of FliC to epithelial cell invasion by enterohemorrhagic Escherichia coli O113:H21. Infect Immun 2006;74:6999-7004. [PMID: 16982828 DOI: 10.1128/IAI.00435-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
235 Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J Am Soc Nephrol 2014;25:1786-98. [PMID: 24578132 DOI: 10.1681/ASN.2013050450] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
236 Bellmeyer A, Cotton C, Kanteti R, Koutsouris A, Viswanathan VK, Hecht G. Enterohemorrhagic Escherichia coli suppresses inflammatory response to cytokines and its own toxin. Am J Physiol Gastrointest Liver Physiol 2009;297:G576-81. [PMID: 19556613 DOI: 10.1152/ajpgi.00050.2009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
237 Ullrich S, Bremer P, Neumann-Grutzeck C, Otto H, Rüther C, von Seydewitz CU, Meyer GP, Ahmadi-Simab K, Röther J, Hogan B, Schwenk W, Fischbach R, Caselitz J, Puttfarcken J, Huggett S, Tiedeken P, Pober J, Kirkiles-Smith NC, Hagenmüller F. Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study. PLoS One 2013;8:e55278. [PMID: 23460784 DOI: 10.1371/journal.pone.0055278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
238 Hunt JM. Shiga toxin-producing Escherichia coli (STEC). Clin Lab Med 2010;30:21-45. [PMID: 20513540 DOI: 10.1016/j.cll.2009.11.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
239 Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut Microbiota and Intestinal Trans-Epithelial Permeability. Int J Mol Sci 2020;21:E6402. [PMID: 32899147 DOI: 10.3390/ijms21176402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
240 Sheerin NS, Glover E. Haemolytic uremic syndrome: diagnosis and management. F1000Res 2019;8:F1000 Faculty Rev-1690. [PMID: 31598213 DOI: 10.12688/f1000research.19957.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
241 Buelli S, Zoja C, Remuzzi G, Morigi M. Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome. Microorganisms 2019;7:E15. [PMID: 30634669 DOI: 10.3390/microorganisms7010015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
242 Wijnsma KL, van Bommel SA, van der Velden T, Volokhina E, Schreuder MF, van den Heuvel LP, van de Kar NC. Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr Nephrol 2016;31:2163-70. [PMID: 27240858 DOI: 10.1007/s00467-016-3420-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
243 Falup-Pecurariu O, Lixandru RI, Cojocaru E, Csutak K, Monescu V, Muhsen K, Falup-Pecurariu C, Cohen D. Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania. Gut Pathog 2019;11:46. [PMID: 31572497 DOI: 10.1186/s13099-019-0327-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
244 Kavanagh D, Goodship T. Genetics and complement in atypical HUS. Pediatr Nephrol 2010;25:2431-42. [PMID: 20526633 DOI: 10.1007/s00467-010-1555-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 98] [Article Influence: 9.8] [Reference Citation Analysis]
245 Gu J, Ji X, Qi J, Ma Y, Mao X, Zou Q. Crystallization and preliminary crystallographic studies of the C-terminal domain of outer membrane protein A from enterohaemorrhagic Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun 2010;66:929-31. [PMID: 20693671 DOI: 10.1107/S1744309110016891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Choi HS, Cheong HI, Kim NK, Oh D, Park HW. ADAMTS13 gene mutations in children with hemolytic uremic syndrome. Yonsei Med J 2011;52:530-4. [PMID: 21488199 DOI: 10.3349/ymj.2011.52.3.530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
247 Mellmann A, Fruth A, Friedrich AW, Wieler LH, Harmsen D, Werber D, Middendorf B, Bielaszewska M, Karch H. Phylogeny and disease association of Shiga toxin-producing Escherichia coli O91. Emerg Infect Dis 2009;15:1474-7. [PMID: 19788818 DOI: 10.3201/eid1509.090161] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
248 Xicohtencatl-Cortes J, Monteiro-Neto V, Saldaña Z, Ledesma MA, Puente JL, Girón JA. The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes. J Bacteriol 2009;191:411-21. [PMID: 18952791 DOI: 10.1128/JB.01306-08] [Cited by in Crossref: 66] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
249 Liebchen A, Benz I, Mellmann A, Karch H, Gomes TA, Yamamoto D, Hernandes RT, Sampaio J, Sampaio SC, Fruth A, Schmidt MA. Characterization of Escherichia coli strains isolated from patients with diarrhea in Sao Paulo, Brazil: identification of intermediate virulence factor profiles by multiplex PCR. J Clin Microbiol 2011;49:2274-8. [PMID: 21508159 DOI: 10.1128/JCM.00386-11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
250 Tesh VL. Activation of cell stress response pathways by Shiga toxins. Cell Microbiol 2012;14:1-9. [PMID: 21899699 DOI: 10.1111/j.1462-5822.2011.01684.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
251 Iversen H, L' Abée-Lund TM, Aspholm M, Arnesen LP, Lindbäck T. Commensal E. coli Stx2 lysogens produce high levels of phages after spontaneous prophage induction. Front Cell Infect Microbiol 2015;5:5. [PMID: 25692100 DOI: 10.3389/fcimb.2015.00005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
252 Lentz EK, Cherla RP, Jaspers V, Weeks BR, Tesh VL. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage. Infect Immun 2010;78:3689-99. [PMID: 20605983 DOI: 10.1128/IAI.00616-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
253 Ruano-Gallego D, Fernández LÁ. Identification of Nanobodies Blocking Intimate Adherence of Shiga Toxin-Producing Escherichia coli to Epithelial Cells. Methods Mol Biol 2021;2291:253-72. [PMID: 33704757 DOI: 10.1007/978-1-0716-1339-9_11] [Reference Citation Analysis]
254 Kim YG, Lee JH, Gwon G, Kim SI, Park JG, Lee J. Essential Oils and Eugenols Inhibit Biofilm Formation and the Virulence of Escherichia coli O157:H7. Sci Rep 2016;6:36377. [PMID: 27808174 DOI: 10.1038/srep36377] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 11.7] [Reference Citation Analysis]
255 Bumunang EW, McAllister TA, Zaheer R, Ortega Polo R, Stanford K, King R, Niu YD, Ateba CN. Characterization of Non-O157 Escherichia coli from Cattle Faecal Samples in the North-West Province of South Africa. Microorganisms 2019;7:E272. [PMID: 31434244 DOI: 10.3390/microorganisms7080272] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
256 Ozaki M, Kang Y, Tan YS, Pavlov VI, Liu B, Boyle DC, Kushak RI, Skjoedt MO, Grabowski EF, Taira Y, Stahl GL. Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury. Kidney Int 2016;90:774-82. [PMID: 27378476 DOI: 10.1016/j.kint.2016.05.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
257 Li T, Pu F, Yang R, Fang X, Wang J, Guo Y, Chang D, Su L, Guo N, Jiang X, Zhao J, Liu C. Draft genome sequence of Escherichia coli LCT-EC106. J Bacteriol 2012;194:4443-4. [PMID: 22843582 DOI: 10.1128/JB.00853-12] [Cited by in Crossref: 7] [Article Influence: 0.7] [Reference Citation Analysis]
258 Matussek A, Jernberg C, Einemo IM, Monecke S, Ehricht R, Engelmann I, Löfgren S, Mernelius S. Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of shedding: a microarray analysis of isolates from Swedish children. Eur J Clin Microbiol Infect Dis 2017;36:1433-41. [PMID: 28421309 DOI: 10.1007/s10096-017-2950-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
259 Kouzel IU, Pohlentz G, Storck W, Radamm L, Hoffmann P, Bielaszewska M, Bauwens A, Cichon C, Schmidt MA, Mormann M, Karch H, Müthing J. Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells. J Lipid Res 2013;54:692-710. [PMID: 23248329 DOI: 10.1194/jlr.M031781] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
260 Legros N, Pohlentz G, Steil D, Kouzel IU, Liashkovich I, Mellmann A, Karch H, Müthing J. Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells. J Lipid Res 2018;59:1383-401. [PMID: 29866658 DOI: 10.1194/jlr.M083048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
261 Su Z, Tong P, Zhang L, Zhang M, Wang D, Ma K, Zhang Y, Liu Y, Xia L, Xie J. First Isolation and Molecular Characterization of bla CTX-M-121 -Producing Escherichia coli O157:H7 From Cattle in Xinjiang, China. Front Vet Sci 2021;8:574801. [PMID: 34113667 DOI: 10.3389/fvets.2021.574801] [Reference Citation Analysis]
262 Iguchi A, Iyoda S, Kikuchi T, Ogura Y, Katsura K, Ohnishi M, Hayashi T, Thomson NR. A complete view of the genetic diversity of the Escherichia coli O-antigen biosynthesis gene cluster. DNA Res 2015;22:101-7. [PMID: 25428893 DOI: 10.1093/dnares/dsu043] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 12.8] [Reference Citation Analysis]
263 Persad AK, Williams ML, LeJeune JT. Rapid loss of a green fluorescent plasmid in Escherichia coli O157:H7. AIMS Microbiol 2017;3:872-84. [PMID: 31294194 DOI: 10.3934/microbiol.2017.4.872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
264 Ellithi M, Shahid M, Abdullah HM, Bleeker J. Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab. Hematol Transfus Cell Ther 2021;43:364-7. [PMID: 32265146 DOI: 10.1016/j.htct.2020.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
265 Liu F, Huang J, Sadler JE. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways. Blood 2011;118:3392-8. [PMID: 21816831 DOI: 10.1182/blood-2011-06-363648] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
266 Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008--a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis 2014;14:265. [PMID: 24884396 DOI: 10.1186/1471-2334-14-265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
267 Lee MS, Cherla RP, Lentz EK, Leyva-Illades D, Tesh VL. Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by Shiga toxin type 1. Infect Immun 2010;78:3378-91. [PMID: 20515924 DOI: 10.1128/IAI.00342-10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
268 Vikram A, Jesudhasan PR, Pillai SD, Patil BS. Isolimonic acid interferes with Escherichia coli O157:H7 biofilm and TTSS in QseBC and QseA dependent fashion. BMC Microbiol 2012;12:261. [PMID: 23153211 DOI: 10.1186/1471-2180-12-261] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
269 Yara DA, Greig DR, Gally DL, Dallman TJ, Jenkins C. Comparison of Shiga toxin-encoding bacteriophages in highly pathogenic strains of Shiga toxin-producing Escherichia coli O157:H7 in the UK. Microb Genom 2020;6. [PMID: 32100710 DOI: 10.1099/mgen.0.000334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
270 Imamovic L, Jofre J, Schmidt H, Serra-Moreno R, Muniesa M. Phage-mediated Shiga toxin 2 gene transfer in food and water. Appl Environ Microbiol 2009;75:1764-8. [PMID: 19168651 DOI: 10.1128/AEM.02273-08] [Cited by in Crossref: 49] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
271 Mühlen S, Ramming I, Pils MC, Koeppel M, Glaser J, Leong J, Flieger A, Stecher B, Dersch P. Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection. Antimicrob Agents Chemother 2020;64:e02159-19. [PMID: 32015030 DOI: 10.1128/AAC.02159-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
272 Liao YT, Salvador A, Harden LA, Liu F, Lavenburg VM, Li RW, Wu VCH. Characterization of a Lytic Bacteriophage as an Antimicrobial Agent for Biocontrol of Shiga Toxin-Producing Escherichia coli O145 Strains. Antibiotics (Basel) 2019;8:E74. [PMID: 31195679 DOI: 10.3390/antibiotics8020074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
273 Wang LYR, Jokinen CC, Laing CR, Johnson RP, Ziebell K, Gannon VPJ. Multi-Year Persistence of Verotoxigenic Escherichia coli (VTEC) in a Closed Canadian Beef Herd: A Cohort Study. Front Microbiol 2018;9:2040. [PMID: 30233526 DOI: 10.3389/fmicb.2018.02040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
274 Stromberg ZR, Van Goor A, Redweik GAJ, Wymore Brand MJ, Wannemuehler MJ, Mellata M. Pathogenic and non-pathogenic Escherichia coli colonization and host inflammatory response in a defined microbiota mouse model. Dis Model Mech 2018;11:dmm035063. [PMID: 30275104 DOI: 10.1242/dmm.035063] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
275 Park DW, Park JH. Characterization and Food Application of the Novel Lytic Phage BECP10: Specifically Recognizes the O-polysaccharide of Escherichia coli O157:H7. Viruses 2021;13:1469. [PMID: 34452334 DOI: 10.3390/v13081469] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Beddoe T, Paton AW, Le Nours J, Rossjohn J, Paton JC. Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci 2010;35:411-8. [PMID: 20202851 DOI: 10.1016/j.tibs.2010.02.003] [Cited by in Crossref: 143] [Cited by in F6Publishing: 124] [Article Influence: 11.9] [Reference Citation Analysis]
277 Hirakawa H, Suzue K, Takita A, Awazu C, Kurushima J, Tomita H. Roles of the Tol-Pal system in the Type III secretion system and flagella-mediated virulence in enterohemorrhagic Escherichia coli. Sci Rep 2020;10:15173. [PMID: 32968151 DOI: 10.1038/s41598-020-72412-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
278 McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB; Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada. Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children. Clin Infect Dis 2020;70:1643-51. [PMID: 31125419 DOI: 10.1093/cid/ciz432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
279 Keepers TR, Gross LK, Obrig TG. Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect Immun 2007;75:1229-36. [PMID: 17220320 DOI: 10.1128/IAI.01663-06] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
280 Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009;27:621-68. [PMID: 19302049 DOI: 10.1146/annurev.immunol.25.022106.141627] [Cited by in Crossref: 730] [Cited by in F6Publishing: 618] [Article Influence: 56.2] [Reference Citation Analysis]
281 Distler U, Souady J, Hülsewig M, Drmić-Hofman I, Haier J, Friedrich AW, Karch H, Senninger N, Dreisewerd K, Berkenkamp S, Schmidt MA, Peter-Katalinić J, Müthing J. Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS One 2009;4:e6813. [PMID: 19714252 DOI: 10.1371/journal.pone.0006813] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
282 Geelen JM, van der Velden TJ, van den Heuvel LP, Monnens LA. Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol 2007;22:1181-7. [PMID: 17574480 DOI: 10.1007/s00467-007-0512-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
283 Islam MA, Mondol AS, de Boer E, Beumer RR, Zwietering MH, Talukder KA, Heuvelink AE. Prevalence and genetic characterization of shiga toxin-producing Escherichia coli isolates from slaughtered animals in Bangladesh. Appl Environ Microbiol 2008;74:5414-21. [PMID: 18641151 DOI: 10.1128/AEM.00854-08] [Cited by in Crossref: 45] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
284 Volokhina EB, Feitz WJC, Elders LM, van der Velden TJAM, van de Kar NCAJ, van den Heuvel LPWJ. Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular Endothelium. Toxins (Basel) 2020;12:E435. [PMID: 32635212 DOI: 10.3390/toxins12070435] [Reference Citation Analysis]
285 Mukherjee S, Blankenship HM, Rodrigues JA, Mosci RE, Rudrik JT, Manning SD. Antibiotic Susceptibility Profiles and Frequency of Resistance Genes in Clinical Shiga Toxin-Producing Escherichia coli Isolates from Michigan over a 14-Year Period. Antimicrob Agents Chemother 2021;65:e0118921. [PMID: 34424041 DOI: 10.1128/AAC.01189-21] [Reference Citation Analysis]
286 Bibbal D, Loukiadis E, Kérourédan M, Ferré F, Dilasser F, Peytavin de Garam C, Cartier P, Oswald E, Gay E, Auvray F, Brugère H. Prevalence of carriage of Shiga toxin-producing Escherichia coli serotypes O157:H7, O26:H11, O103:H2, O111:H8, and O145:H28 among slaughtered adult cattle in France. Appl Environ Microbiol 2015;81:1397-405. [PMID: 25527532 DOI: 10.1128/AEM.03315-14] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
287 Yun Z, Zeng L, Huang W, Wu Q, Fan Y, Zheng S, Peng L, Han J, Huang Y, Zhou H, Chen H. Detection and Categorization of Diarrheagenic Escherichia coli with Auto-microfluidic Thin-film Chip Method. Sci Rep 2018;8:12926. [PMID: 30150710 DOI: 10.1038/s41598-018-30765-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
288 Amraotkar AR, Hargis CW, Cambon AC, Rai SN, Keith MC, Ghafghazi S, Bolli R, DeFilippis AP. Comparison of coliform contamination in non-municipal waters consumed by the Mennonite versus the non-Mennonite rural populations. Environ Health Prev Med 2015;20:338-46. [PMID: 26068785 DOI: 10.1007/s12199-015-0472-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
289 Rojas-Lopez M, Martinelli M, Brandi V, Jubelin G, Polticelli F, Soriani M, Pizza M, Desvaux M, Rosini R. Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli. Sci Rep 2019;9:17014. [PMID: 31745113 DOI: 10.1038/s41598-019-53197-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
290 Lewis SB, Prior A, Ellis SJ, Cook V, Chan SS, Gelson W, Schüller S. Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli. Front Cell Infect Microbiol 2016;6:68. [PMID: 27446815 DOI: 10.3389/fcimb.2016.00068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
291 Engedal N, Skotland T, Torgersen ML, Sandvig K. Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol 2011;4:32-46. [PMID: 21255370 DOI: 10.1111/j.1751-7915.2010.00180.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
292 Müller D, Greune L, Heusipp G, Karch H, Fruth A, Tschäpe H, Schmidt MA. Identification of unconventional intestinal pathogenic Escherichia coli isolates expressing intermediate virulence factor profiles by using a novel single-step multiplex PCR. Appl Environ Microbiol 2007;73:3380-90. [PMID: 17400780 DOI: 10.1128/AEM.02855-06] [Cited by in Crossref: 128] [Cited by in F6Publishing: 68] [Article Influence: 8.5] [Reference Citation Analysis]
293 Jenssen GR, Vold L, Hovland E, Bangstad HJ, Nygård K, Bjerre A. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008. BMC Infect Dis 2016;16:285. [PMID: 27297224 DOI: 10.1186/s12879-016-1627-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
294 Petruzziello-Pellegrini TN, Marsden PA. Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics. Curr Opin Nephrol Hypertens 2012;21:433-40. [PMID: 22660553 DOI: 10.1097/MNH.0b013e328354a62e] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
295 Iguchi A, Iyoda S, Seto K, Nishii H, Ohnishi M, Mekata H, Ogura Y, Hayashi T. Six Novel O Genotypes from Shiga Toxin-Producing Escherichia coli. Front Microbiol 2016;7:765. [PMID: 27242776 DOI: 10.3389/fmicb.2016.00765] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
296 Huerta-Uribe A, Marjenberg ZR, Yamaguchi N, Fitzgerald S, Connolly JP, Carpena N, Uvell H, Douce G, Elofsson M, Byron O, Marquez R, Gally DL, Roe AJ. Identification and Characterization of Novel Compounds Blocking Shiga Toxin Expression in Escherichia coli O157:H7. Front Microbiol 2016;7:1930. [PMID: 27965652 DOI: 10.3389/fmicb.2016.01930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
297 Zumbrun SD, Melton-Celsa AR, Smith MA, Gilbreath JJ, Merrell DS, O'Brien AD. Dietary choice affects Shiga toxin-producing Escherichia coli (STEC) O157:H7 colonization and disease. Proc Natl Acad Sci U S A 2013;110:E2126-33. [PMID: 23690602 DOI: 10.1073/pnas.1222014110] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 7.8] [Reference Citation Analysis]
298 Kim YJ, Park KH, Park DA, Park J, Bang BW, Lee SS, Lee EJ, Lee HJ, Hong SK, Kim YR. Guideline for the Antibiotic Use in Acute Gastroenteritis. Infect Chemother 2019;51:217-43. [PMID: 31271003 DOI: 10.3947/ic.2019.51.2.217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
299 Boyer O, Niaudet P. Hemolytic uremic syndrome: new developments in pathogenesis and treatment. Int J Nephrol 2011;2011:908407. [PMID: 21876803 DOI: 10.4061/2011/908407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
300 Kobbe R, Schild R, Christner M, Oh J, Loos S, Kemper MJ. Case report - atypical hemolytic uremic syndrome triggered by influenza B. BMC Nephrol 2017;18:96. [PMID: 28320387 DOI: 10.1186/s12882-017-0512-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
301 Jenke C, Leopold SR, Weniger T, Rothgänger J, Harmsen D, Karch H, Mellmann A. Identification of intermediate in evolutionary model of enterohemorrhagic Escherichia coli O157. Emerg Infect Dis 2012;18:582-8. [PMID: 22469031 DOI: 10.3201/eid1804.111414] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
302 Holmes A, Allison L, Ward M, Dallman TJ, Clark R, Fawkes A, Murphy L, Hanson M. Utility of Whole-Genome Sequencing of Escherichia coli O157 for Outbreak Detection and Epidemiological Surveillance. J Clin Microbiol 2015;53:3565-73. [PMID: 26354815 DOI: 10.1128/JCM.01066-15] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
303 Loos S, Oh J, Kemper MJ. Eculizumab in STEC-HUS: need for a proper randomized controlled trial. Pediatr Nephrol 2018;33:1277-81. [PMID: 29774464 DOI: 10.1007/s00467-018-3972-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
304 Prateeksha, Barik SK, Singh BN. Nanoemulsion-loaded hydrogel coatings for inhibition of bacterial virulence and biofilm formation on solid surfaces. Sci Rep 2019;9:6520. [PMID: 31019240 DOI: 10.1038/s41598-019-43016-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
305 Bitzan M, Poole R, Mehran M, Sicard E, Brockus C, Thuning-Roberson C, Rivière M. Safety and pharmacokinetics of chimeric anti-Shiga toxin 1 and anti-Shiga toxin 2 monoclonal antibodies in healthy volunteers. Antimicrob Agents Chemother 2009;53:3081-7. [PMID: 19414580 DOI: 10.1128/AAC.01661-08] [Cited by in Crossref: 56] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
306 Rojas RL, Gomes PA, Bentancor LV, Sbrogio-Almeida ME, Costa SO, Massis LM, Ferreira RC, Palermo MS, Ferreira LC. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli. Clin Vaccine Immunol 2010;17:529-36. [PMID: 20147499 DOI: 10.1128/CVI.00495-09] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
307 Gaytán MO, Martínez-Santos VI, Soto E, González-Pedrajo B. Type Three Secretion System in Attaching and Effacing Pathogens. Front Cell Infect Microbiol 2016;6:129. [PMID: 27818950 DOI: 10.3389/fcimb.2016.00129] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 12.5] [Reference Citation Analysis]
308 Ruano-Gallego D, Yara DA, Di Ianni L, Frankel G, Schüller S, Fernández LÁ. A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa. PLoS Pathog 2019;15:e1008031. [PMID: 31465434 DOI: 10.1371/journal.ppat.1008031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
309 Song L, Xiao Y, Li X, Huang Y, Meng G, Ren Z. Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model. Front Immunol 2020;11:619096. [PMID: 33552083 DOI: 10.3389/fimmu.2020.619096] [Reference Citation Analysis]
310 Bauwens A, Betz J, Meisen I, Kemper B, Karch H, Müthing J. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell Mol Life Sci 2013;70:425-57. [PMID: 22766973 DOI: 10.1007/s00018-012-1060-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
311 Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE. Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 2013;28:919-25. [PMID: 23386110 DOI: 10.1007/s00467-013-2414-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
312 Ingelbeen B, Bruyand M, Mariani-Kurkjian P, Le Hello S, Danis K, Sommen C, Bonacorsi S, de Valk H. Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups. PLoS One 2018;13:e0207492. [PMID: 30419067 DOI: 10.1371/journal.pone.0207492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
313 Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Næss PA, Bangstad HJ. Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med 2011;19:44. [PMID: 21798000 DOI: 10.1186/1757-7241-19-44] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
314 Travert B, Rafat C, Mariani P, Cointe A, Dossier A, Coppo P, Joseph A. Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management. Toxins (Basel) 2021;13:306. [PMID: 33925836 DOI: 10.3390/toxins13050306] [Reference Citation Analysis]
315 Sawyer C, Vishram B, Jenkins C, Jorgensen F, Byrne L, Mikhail AFW, Dallman TJ, Carroll K, Ahyow L, Vahora Q, Godbole G, Balasegaram S. Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli serotype O55:H7 in England, 2014-2018. Epidemiol Infect 2021;149:e108. [PMID: 33866980 DOI: 10.1017/S0950268821000844] [Reference Citation Analysis]
316 Holm LP, Hawkins I, Robin C, Newton RJ, Jepson R, Stanzani G, McMahon LA, Pesavento P, Carr T, Cogan T, Couto CG, Cianciolo R, Walker DJ. Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK. Vet Rec 2015;176:384. [PMID: 25802439 DOI: 10.1136/vr.102892] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
317 Nguyen TC, Cruz MA, Carcillo JA. Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury. Crit Care Clin 2015;31:661-74. [PMID: 26410136 DOI: 10.1016/j.ccc.2015.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
318 Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 2011;6:e22751. [PMID: 21799941 DOI: 10.1371/journal.pone.0022751] [Cited by in Crossref: 565] [Cited by in F6Publishing: 451] [Article Influence: 51.4] [Reference Citation Analysis]
319 Brigotti M, Orth-Höller D, Carnicelli D, Porcellini E, Galassi E, Tazzari PL, Ricci F, Manoli F, Manet I, Talasz H, Lindner HH, Speth C, Erbeznik T, Fuchs S, Posch W, Chatterjee S, Würzner R. The structure of the Shiga toxin 2a A-subunit dictates the interactions of the toxin with blood components. Cell Microbiol 2019;21:e13000. [PMID: 30578712 DOI: 10.1111/cmi.13000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
320 Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis 2008;2008:290769. [PMID: 19277100 DOI: 10.1155/2008/290769] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
321 Page AV, Tarr PI, Watkins SL, Rajwans N, Petruzziello-Pellegrini TN, Marsden PA, Kain KC, Liles WC. Dysregulation of angiopoietin 1 and 2 in Escherichia coli O157:H7 infection and the hemolytic-uremic syndrome. J Infect Dis 2013;208:929-33. [PMID: 23801605 DOI: 10.1093/infdis/jit268] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
322 Johannes L, Römer W. Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol 2010;8:105-16. [PMID: 20023663 DOI: 10.1038/nrmicro2279] [Cited by in Crossref: 321] [Cited by in F6Publishing: 293] [Article Influence: 24.7] [Reference Citation Analysis]
323 Yenerel MN. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management. Turk J Haematol 2014;31:216-25. [PMID: 25319590 DOI: 10.4274/tjh.2013.0374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
324 Stearns-Kurosawa DJ, Collins V, Freeman S, Debord D, Nishikawa K, Oh SY, Leibowitz CS, Kurosawa S. Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide. Pediatr Nephrol 2011;26:2031-9. [PMID: 21603905 DOI: 10.1007/s00467-011-1913-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
325 Tree JJ, Granneman S, McAteer SP, Tollervey D, Gally DL. Identification of bacteriophage-encoded anti-sRNAs in pathogenic Escherichia coli. Mol Cell 2014;55:199-213. [PMID: 24910100 DOI: 10.1016/j.molcel.2014.05.006] [Cited by in Crossref: 165] [Cited by in F6Publishing: 145] [Article Influence: 20.6] [Reference Citation Analysis]
326 Fegan N, Gobius KS. Pathogenic Escherichia coli and One Health Implications. In: Mackenzie JS, Jeggo M, Daszak P, Richt JA, editors. One Health: The Human-Animal-Environment Interfaces in Emerging Infectious Diseases. Berlin: Springer Berlin Heidelberg; 2013. pp. 49-62. [DOI: 10.1007/978-3-662-45791-7_261] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
327 Jandu N, Ho NK, Donato KA, Karmali MA, Mascarenhas M, Duffy SP, Tailor C, Sherman PM. Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia. PLoS One 2009;4:e4889. [PMID: 19293938 DOI: 10.1371/journal.pone.0004889] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
328 Terajima J, Izumiya H, Hara-Kudo Y, Ohnishi M. Shiga Toxin (Verotoxin)-producing 
Escherichia coli and Foodborne Disease: 
A Review. Food Saf (Tokyo) 2017;5:35-53. [PMID: 32231928 DOI: 10.14252/foodsafetyfscj.2016029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
329 Loconsole D, Giordano M, Centrone F, Accogli M, Casulli D, De Robertis AL, Morea A, Quarto M, Parisi A, Scavia G, Chironna M, On Behalf Of The Bloody Diarrhea Apulia Working Group. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy after Implementation of Symptom-Based Surveillance of Bloody Diarrhea in the Pediatric Population. Int J Environ Res Public Health 2020;17:E5137. [PMID: 32708640 DOI: 10.3390/ijerph17145137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
330 Platenkamp A, Mellies JL. Environment Controls LEE Regulation in Enteropathogenic Escherichia coli. Front Microbiol 2018;9:1694. [PMID: 30140259 DOI: 10.3389/fmicb.2018.01694] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
331 Kouzel IU, Pohlentz G, Schmitz JS, Steil D, Humpf HU, Karch H, Müthing J. Shiga Toxin Glycosphingolipid Receptors in Human Caco-2 and HCT-8 Colon Epithelial Cell Lines. Toxins (Basel) 2017;9:E338. [PMID: 29068380 DOI: 10.3390/toxins9110338] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
332 Navarro A, Licona-Moreno D, Monsalvo-Reyes A, Hernández-Chiñas U, Eslava-Campos CA. Phage Display Detection of Mimotopes that Are Shared Epitopes of Clinically and Epidemiologically Relevant Enterobacteria. Microorganisms 2020;8:E780. [PMID: 32455888 DOI: 10.3390/microorganisms8050780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
333 Macion A, Wyszyńska A, Godlewska R. Delivery of Toxins and Effectors by Bacterial Membrane Vesicles. Toxins (Basel) 2021;13:845. [PMID: 34941684 DOI: 10.3390/toxins13120845] [Reference Citation Analysis]
334 Pandey Y, Atwal D, Sasapu A. Diarrhea-associated Hemolytic Uremic Syndrome in Adults: Two Case Reports and Review of the Literature. Cureus 2019;11:e4435. [PMID: 31245222 DOI: 10.7759/cureus.4435] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
335 Jang J, Di DY, Lee A, Unno T, Sadowsky MJ, Hur HG. Seasonal and genotypic changes in escherichia coli phylogenetic groups in the Yeongsan River basin of South Korea. PLoS One 2014;9:e100585. [PMID: 24999864 DOI: 10.1371/journal.pone.0100585] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
336 Hauser JR, Atitkar RR, Petro CD, Lindsey RL, Strockbine N, O'Brien AD, Melton-Celsa AR. The Virulence of Escherichia coli O157:H7 Isolates in Mice Depends on Shiga Toxin Type 2a (Stx2a)-Induction and High Levels of Stx2a in Stool. Front Cell Infect Microbiol 2020;10:62. [PMID: 32175286 DOI: 10.3389/fcimb.2020.00062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
337 Szabady RL, Lokuta MA, Walters KB, Huttenlocher A, Welch RA. Modulation of neutrophil function by a secreted mucinase of Escherichia coli O157:H7. PLoS Pathog 2009;5:e1000320. [PMID: 19247439 DOI: 10.1371/journal.ppat.1000320] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
338 McGannon CM, Fuller CA, Weiss AA. Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother 2010;54:3790-8. [PMID: 20585113 DOI: 10.1128/AAC.01783-09] [Cited by in Crossref: 119] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
339 Brigotti M. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 2012;4:157-90. [PMID: 22741061 DOI: 10.3390/toxins4030157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
340 Laberge K, Galanis E. Evaluation of the surveillance of hemolytic uremic syndrome in British Columbia: should it remain reportable? Can J Public Health 2008;99:286-9. [PMID: 18767272 [PMID: 18767272 DOI: 10.1007/bf03403756] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
341 Boontiam W, Wachirapakorn C, Phaengphairee P. Effects of hydrolyzed yeast supplementation on growth performance, immunity, antioxidant capacity, and microbial shedding in weaning pigs. Vet World 2020;13:1902-9. [PMID: 33132604 DOI: 10.14202/vetworld.2020.1902-1909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Bielaszewska M, Rüter C, Bauwens A, Greune L, Jarosch KA, Steil D, Zhang W, He X, Lloubes R, Fruth A, Kim KS, Schmidt MA, Dobrindt U, Mellmann A, Karch H. Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury. PLoS Pathog 2017;13:e1006159. [PMID: 28158302 DOI: 10.1371/journal.ppat.1006159] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 17.2] [Reference Citation Analysis]
343 Cai K, Tu W, Liu Y, Li T, Wang H. Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7. Sci Rep 2015;5:17479. [PMID: 26626573 DOI: 10.1038/srep17479] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
344 Mellor GE, Besser TE, Davis MA, Beavis B, Jung W, Smith HV, Jennison AV, Doyle CJ, Chandry PS, Gobius KS, Fegan N. Multilocus genotype analysis of Escherichia coli O157 isolates from Australia and the United States provides evidence of geographic divergence. Appl Environ Microbiol 2013;79:5050-8. [PMID: 23770913 DOI: 10.1128/AEM.01525-13] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
345 Mallick EM, Garber JJ, Vanguri VK, Balasubramanian S, Blood T, Clark S, Vingadassalom D, Louissaint C, McCormick B, Snapper SB, Leong JM. The ability of an attaching and effacing pathogen to trigger localized actin assembly contributes to virulence by promoting mucosal attachment. Cell Microbiol 2014;16:1405-24. [PMID: 24780054 DOI: 10.1111/cmi.12302] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
346 Feitz WJC, Suntharalingham S, Khan M, Ortiz-Sandoval CG, Palaniyar N, van den Heuvel LP, van de Kar NCAJ, Licht C. Shiga Toxin 2a Induces NETosis via NOX-Dependent Pathway. Biomedicines 2021;9:1807. [PMID: 34944623 DOI: 10.3390/biomedicines9121807] [Reference Citation Analysis]
347 Wadehra A, Alkassis S. Atypical Hemolytic Uremic Syndrome in the Setting of Acute Clostridium difficile Colitis. Cureus 2021;13:e13244. [PMID: 33728192 DOI: 10.7759/cureus.13244] [Reference Citation Analysis]
348 Dowen F, Wood K, Brown AL, Palfrey J, Kavanagh D, Brocklebank V. Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential. Clin Kidney J 2017;10:490-3. [PMID: 28852487 DOI: 10.1093/ckj/sfx030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
349 Jacobson JM, Yin J, Kitov PI, Mulvey G, Griener TP, James MN, Armstrong G, Bundle DR. The crystal structure of shiga toxin type 2 with bound disaccharide guides the design of a heterobifunctional toxin inhibitor. J Biol Chem 2014;289:885-94. [PMID: 24225957 DOI: 10.1074/jbc.M113.518886] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
350 Braeye T, Denayer S, De Rauw K, Forier A, Verluyten J, Fourie L, Dierick K, Botteldoorn N, Quoilin S, Cosse P, Noyen J, Pierard D. Lessons learned from a textbook outbreak: EHEC-O157:H7 infections associated with the consumption of raw meat products, June 2012, Limburg, Belgium. Arch Public Health 2014;72:44. [PMID: 25810911 DOI: 10.1186/2049-3258-72-44] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
351 Arimitsu H, Sasaki K, Kojima H, Yanaka T, Tsuji T. Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group. PLoS One 2013;8:e83577. [PMID: 24340102 DOI: 10.1371/journal.pone.0083577] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
352 Brookes VJ, Jordan D, Davis S, Ward MP, Heller J. Saltelli Global Sensitivity Analysis and Simulation Modelling to Identify Intervention Strategies to Reduce the Prevalence of Escherichia coli O157 Contaminated Beef Carcasses. PLoS One 2015;10:e0146016. [PMID: 26713610 DOI: 10.1371/journal.pone.0146016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
353 Bruballa AC, Shiromizu CM, Bernal AM, Pineda GE, Sabbione F, Trevani AS, Bentancor LV, Ramos MV, Fernández-Brando RJ, Muñoz MJ, Palermo MS. Role of Shiga Toxins in Cytotoxicity and Immunomodulatory Effects of Escherichia coli O157:H7 during Host-Bacterial Interactions in vitro. Toxins (Basel) 2020;12:E48. [PMID: 31947665 DOI: 10.3390/toxins12010048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
354 Arfilli V, Carnicelli D, Ardissino G, Torresani E, Scavia G, Brigotti M. A rapid and sensitive method to measure the functional activity of Shiga toxins in human serum. Toxins (Basel) 2015;7:4564-76. [PMID: 26556372 DOI: 10.3390/toxins7114564] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
355 Serra-Moreno R, Jofre J, Muniesa M. The CI repressors of Shiga toxin-converting prophages are involved in coinfection of Escherichia coli strains, which causes a down regulation in the production of Shiga toxin 2. J Bacteriol 2008;190:4722-35. [PMID: 18469095 DOI: 10.1128/JB.00069-08] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
356 Holmes A, Dallman TJ, Shabaan S, Hanson M, Allison L. Validation of Whole-Genome Sequencing for Identification and Characterization of Shiga Toxin-Producing Escherichia coli To Produce Standardized Data To Enable Data Sharing. J Clin Microbiol 2018;56:e01388-17. [PMID: 29263202 DOI: 10.1128/JCM.01388-17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
357 Gupta N, Pons V, Noël R, Buisson DA, Michau A, Johannes L, Gillet D, Barbier J, Cintrat JC. (S)-N-Methyldihydroquinazolinones are the Active Enantiomers of Retro-2 Derived Compounds against Toxins. ACS Med Chem Lett 2014;5:94-7. [PMID: 24900779 DOI: 10.1021/ml400457j] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
358 Bielaszewska M, Zhang W, Tarr PI, Sonntag AK, Karch H. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol 2005;43:4225-8. [PMID: 16081985 DOI: 10.1128/JCM.43.8.4225-4228.2005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
359 Geue L, Stieber B, Monecke S, Engelmann I, Gunzer F, Slickers P, Braun SD, Ehricht R. Development of a rapid microarray-based DNA subtyping assay for the alleles of Shiga toxins 1 and 2 of Escherichia coli. J Clin Microbiol 2014;52:2898-904. [PMID: 24899022 DOI: 10.1128/JCM.01048-14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
360 Bentancor LV, Mejías MP, Pinto A, Bilen MF, Meiss R, Rodriguez-Galán MC, Baez N, Pedrotti LP, Goldstein J, Ghiringhelli PD, Palermo MS. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2. mBio 2013;4:e00501-13. [PMID: 24085779 DOI: 10.1128/mBio.00501-13] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
361 Rasa M, Musgrave J, Abe K, Tanaka L, Xoinis K, Shiramizu B, Foskett G, Lau R. A Case of Escherichia coli Hemolytic Uremic Syndrome in a 10-Year-Old Male With Severe Neurologic Involvement Successfully Treated With Eculizumab. J Investig Med High Impact Case Rep 2017;5:2324709617741144. [PMID: 29152520 DOI: 10.1177/2324709617741144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
362 Tian S, Muneeruddin K, Choi MY, Tao L, Bhuiyan RH, Ohmi Y, Furukawa K, Furukawa K, Boland S, Shaffer SA, Adam RM, Dong M. Genome-wide CRISPR screens for Shiga toxins and ricin reveal Golgi proteins critical for glycosylation. PLoS Biol 2018;16:e2006951. [PMID: 30481169 DOI: 10.1371/journal.pbio.2006951] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
363 Teel LD, Daly JA, Jerris RC, Maul D, Svanas G, O'Brien AD, Park CH. Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay. J Clin Microbiol 2007;45:3377-80. [PMID: 17670920 DOI: 10.1128/JCM.00837-07] [Cited by in Crossref: 36] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
364 Fidan K, Kandur Y, Ucar M, Gucuyener K, Soylemezoglu O. Posterior Reversible Encephalopathy Syndrome in Henoch-Schonlein Purpura and Hemolytic Uremic Syndrome. J Clin Med Res 2016;8:544-7. [PMID: 27298664 DOI: 10.14740/jocmr2157w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
365 Timmons C, Trees E, Ribot EM, Gerner-Smidt P, LaFon P, Im S, Ma LM. Multiple-locus variable-number tandem repeat analysis for strain discrimination of non-O157 Shiga toxin-producing Escherichia coli. J Microbiol Methods 2016;125:70-80. [PMID: 27071532 DOI: 10.1016/j.mimet.2016.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
366 Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases. Acta Biomed 2018;89:153-7. [PMID: 30561409 DOI: 10.23750/abm.v89i9-S.7911] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
367 Díaz L, Gutierrez S, Moreno-Switt AI, Hervé LP, Hamilton-West C, Padola NL, Navarrete P, Reyes-Jara A, Meng J, González-Escalona N, Toro M. Diversity of Non-O157 Shiga Toxin-Producing Escherichia coli Isolated from Cattle from Central and Southern Chile. Animals (Basel) 2021;11:2388. [PMID: 34438845 DOI: 10.3390/ani11082388] [Reference Citation Analysis]
368 Pearce MC, Chase-Topping ME, McKendrick IJ, Mellor DJ, Locking ME, Allison L, Ternent HE, Matthews L, Knight HI, Smith AW, Synge BA, Reilly W, Low JC, Reid SW, Gunn GJ, Woolhouse ME. Temporal and spatial patterns of bovine Escherichia coli O157 prevalence and comparison of temporal changes in the patterns of phage types associated with bovine shedding and human E. coli O157 cases in Scotland between 1998-2000 and 2002-2004. BMC Microbiol 2009;9:276. [PMID: 20040112 DOI: 10.1186/1471-2180-9-276] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
369 Wood TK. Insights on Escherichia coli biofilm formation and inhibition from whole-transcriptome profiling. Environ Microbiol 2009;11:1-15. [PMID: 19125816 DOI: 10.1111/j.1462-2920.2008.01768.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 9.8] [Reference Citation Analysis]
370 Nguyen Y, Sperandio V. Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol 2012;2:90. [PMID: 22919681 DOI: 10.3389/fcimb.2012.00090] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 14.4] [Reference Citation Analysis]
371 Hall G, Kurosawa S, Stearns-Kurosawa DJ. Dextran Sulfate Sodium Colitis Facilitates Colonization with Shiga Toxin-Producing Escherichia coli: a Novel Murine Model for the Study of Shiga Toxicosis. Infect Immun 2018;86:e00530-18. [PMID: 30150257 DOI: 10.1128/IAI.00530-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
372 Karnisova L, Hradsky O, Blahova K, Fencl F, Dolezel Z, Zaoral T, Zieg J. Complement activation is associated with more severe course of diarrhea-associated hemolytic uremic syndrome, a preliminary study. Eur J Pediatr 2018;177:1837-44. [PMID: 30251107 DOI: 10.1007/s00431-018-3255-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
373 Pennington TH. E. coli O157 outbreaks in the United Kingdom: past, present, and future. Infect Drug Resist 2014;7:211-22. [PMID: 25187729 DOI: 10.2147/IDR.S49081] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
374 Wang X, Taylor M, Hoang L, Ekkert J, Nowakowski C, Stone J, Tone G, Trerise S, Paccagnella A, Wong T, Galanis E. Comparison of clinical and epidemiological features of Shiga toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 2011. Can J Infect Dis Med Microbiol 2013;24:e102-6. [PMID: 24489568 DOI: 10.1155/2013/932752] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
375 Bielaszewska M, Greune L, Bauwens A, Dersch P, Mellmann A, Rüter C. Virulence Factor Cargo and Host Cell Interactions of Shiga Toxin-Producing Escherichia coli Outer Membrane Vesicles. Methods Mol Biol 2021;2291:177-205. [PMID: 33704754 DOI: 10.1007/978-1-0716-1339-9_8] [Reference Citation Analysis]
376 Vinh PT, Shinohara Y, Yamada A, Duc HM, Nakayama M, Ozawa T, Sato J, Masuda Y, Honjoh KI, Miyamoto T. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli. Toxins (Basel) 2019;11:E505. [PMID: 31470657 DOI: 10.3390/toxins11090505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
377 Kato M, Watanabe-Takahashi M, Shimizu E, Nishikawa K. Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane. Appl Environ Microbiol 2015;81:1092-100. [PMID: 25452283 DOI: 10.1128/AEM.03517-14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
378 Huang J, Chen G, Ma L, Tan T. Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children. J Int Med Res 2020;48:300060519896445. [PMID: 32090665 DOI: 10.1177/0300060519896445] [Reference Citation Analysis]
379 Perera A, Clarke CM, Dykes GA, Fegan N. Characterization of Shiga Toxigenic Escherichia coli O157 and Non-O157 Isolates from Ruminant Feces in Malaysia. Biomed Res Int 2015;2015:382403. [PMID: 26539484 DOI: 10.1155/2015/382403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
380 Gaston MA, Pellino CA, Weiss AA. Failure of manganese to protect from Shiga toxin. PLoS One 2013;8:e69823. [PMID: 23875002 DOI: 10.1371/journal.pone.0069823] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
381 Aas CG, Drabløs F, Haugum K, Afset JE. Comparative Transcriptome Profiling Reveals a Potential Role of Type VI Secretion System and Fimbriae in Virulence of Non-O157 Shiga Toxin-Producing Escherichia coli. Front Microbiol 2018;9:1416. [PMID: 30008706 DOI: 10.3389/fmicb.2018.01416] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
382 Kavaliauskiene S, Dyve Lingelem AB, Skotland T, Sandvig K. Protection against Shiga Toxins. Toxins (Basel) 2017;9:E44. [PMID: 28165371 DOI: 10.3390/toxins9020044] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
383 Bugarel M, Beutin L, Scheutz F, Loukiadis E, Fach P. Identification of genetic markers for differentiation of Shiga toxin-producing, enteropathogenic, and avirulent strains of Escherichia coli O26. Appl Environ Microbiol 2011;77:2275-81. [PMID: 21317253 DOI: 10.1128/AEM.02832-10] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
384 Bonanno L, Loukiadis E, Mariani-Kurkdjian P, Oswald E, Garnier L, Michel V, Auvray F. Diversity of Shiga Toxin-Producing Escherichia coli (STEC) O26:H11 Strains Examined via stx Subtypes and Insertion Sites of Stx and EspK Bacteriophages. Appl Environ Microbiol 2015;81:3712-21. [PMID: 25819955 DOI: 10.1128/AEM.00077-15] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
385 Ylinen E, Salmenlinna S, Halkilahti J, Jahnukainen T, Korhonen L, Virkkala T, Rimhanen-Finne R, Nuutinen M, Kataja J, Arikoski P, Linkosalo L, Bai X, Matussek A, Jalanko H, Saxén H. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in children: incidence, risk factors, and clinical outcome. Pediatr Nephrol 2020;35:1749-59. [PMID: 32323005 DOI: 10.1007/s00467-020-04560-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
386 Khalid M, Andreoli S. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS). Pediatr Nephrol 2019;34:2495-507. [PMID: 30382336 DOI: 10.1007/s00467-018-4105-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
387 Brzuszkiewicz E, Thürmer A, Schuldes J, Leimbach A, Liesegang H, Meyer FD, Boelter J, Petersen H, Gottschalk G, Daniel R. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol 2011;193:883-91. [PMID: 21713444 DOI: 10.1007/s00203-011-0725-6] [Cited by in Crossref: 193] [Cited by in F6Publishing: 166] [Article Influence: 17.5] [Reference Citation Analysis]
388 Martínez-Castillo A, Muniesa M. Implications of free Shiga toxin-converting bacteriophages occurring outside bacteria for the evolution and the detection of Shiga toxin-producing Escherichia coli. Front Cell Infect Microbiol 2014;4:46. [PMID: 24795866 DOI: 10.3389/fcimb.2014.00046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
389 Robertson CD, Hazen TH, Kaper JB, Rasko DA, Hansen AM. Phosphotyrosine-Mediated Regulation of Enterohemorrhagic Escherichia coli Virulence. mBio 2018;9:e00097-18. [PMID: 29487233 DOI: 10.1128/mBio.00097-18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
390 Watanabe-Takahashi M, Yamasaki S, Murata M, Kano F, Motoyama J, Yamate J, Omi J, Sato W, Ukai H, Shimasaki K, Ikegawa M, Tamura-Nakano M, Yanoshita R, Nishino Y, Miyazawa A, Natori Y, Toyama-Sorimachi N, Nishikawa K. Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice. Sci Rep 2018;8:10776. [PMID: 30018364 DOI: 10.1038/s41598-018-29128-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
391 Schüller S. Shiga toxin interaction with human intestinal epithelium. Toxins (Basel) 2011;3:626-39. [PMID: 22069729 DOI: 10.3390/toxins3060626] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 6.4] [Reference Citation Analysis]
392 Asakura H, Ikeda T, Yamamoto S, Kabeya H, Sugiyama H, Takai S. Draft Genome Sequence of Five Shiga Toxin-Producing Escherichia coli Strains Isolated from Wild Deer in Japan. Genome Announc 2017;5:e01455-16. [PMID: 28254967 DOI: 10.1128/genomeA.01455-16] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
393 Lee MS, Tesh VL. Roles of Shiga Toxins in Immunopathology. Toxins (Basel) 2019;11:E212. [PMID: 30970547 DOI: 10.3390/toxins11040212] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
394 Bray MA, Sartain SE, Gollamudi J, Rumbaut RE. Microvascular thrombosis: experimental and clinical implications. Transl Res 2020;225:105-30. [PMID: 32454092 DOI: 10.1016/j.trsl.2020.05.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
395 Maguire M, Kase JA, Roberson D, Muruvanda T, Brown EW, Allard M, Musser SM, González-Escalona N. Precision long-read metagenomics sequencing for food safety by detection and assembly of Shiga toxin-producing Escherichia coli in irrigation water. PLoS One 2021;16:e0245172. [PMID: 33444384 DOI: 10.1371/journal.pone.0245172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
396 Xu X, McAteer SP, Tree JJ, Shaw DJ, Wolfson EB, Beatson SA, Roe AJ, Allison LJ, Chase-Topping ME, Mahajan A, Tozzoli R, Woolhouse ME, Morabito S, Gally DL. Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli. PLoS Pathog 2012;8:e1002672. [PMID: 22615557 DOI: 10.1371/journal.ppat.1002672] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
397 Rocha LB, Santos AR, Munhoz DD, Cardoso LT, Luz DE, Andrade FB, Horton DS, Elias WP, Piazza RM. Development of a rapid agglutination latex test for diagnosis of enteropathogenic and enterohemorrhagic Escherichia coli infection in developing world: defining the biomarker, antibody and method. PLoS Negl Trop Dis 2014;8:e3150. [PMID: 25254981 DOI: 10.1371/journal.pntd.0003150] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
398 Feitz WJC, Bouwmeester R, van der Velden TJAM, Goorden S, Licht C, van den Heuvel LPJW, van de Kar NCAJ. The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS. Microorganisms 2021;9:2157. [PMID: 34683478 DOI: 10.3390/microorganisms9102157] [Reference Citation Analysis]
399 Tominaga T, Oikawa M, Takeshita H, Kunizaki M, Tou K, Abo T, Hidaka S, Nanashima A, Sawai T, Nagayasu T. Successful Colectomy for Hemorrhagic Colitis with Hemolytic Uremic Syndrome and Acute Encephalopathy due to Escherichia coli O157 Infection. Case Rep Gastroenterol 2014;8:82-8. [PMID: 24803891 DOI: 10.1159/000360846] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
400 Aw W, Fukuda S. Protective effects of bifidobacteria against enteropathogens. Microb Biotechnol 2019;12:1097-100. [PMID: 31284329 DOI: 10.1111/1751-7915.13460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
401 Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011;86:743-51. [PMID: 21850657 DOI: 10.1002/ajh.22091] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
402 Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469:543-547. [PMID: 21270894 DOI: 10.1083/nature09646] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
403 Malyukova I, Murray KF, Zhu C, Boedeker E, Kane A, Patterson K, Peterson JR, Donowitz M, Kovbasnjuk O. Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G78-G92. [PMID: 18974311 DOI: 10.1152/ajpgi.90347.2008] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 4.6] [Reference Citation Analysis]
404 Ranjbar R, Erfanmanesh M, Afshar D, Mohammadi M, Ghaderi O, Haghnazari A. Visual Detection of Enterohemorrhagic Escherichia coli O157:H7 Using Loop-Mediated Isothermal Amplification. Electron Physician 2016;8:2576-85. [PMID: 27504175 DOI: 10.19082/2576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
405 Foster MA, Iqbal J, Zhang C, McHenry R, Cleveland BE, Romero-Herazo Y, Fonnesbeck C, Payne DC, Chappell JD, Halasa N, Gómez-Duarte OG. Enteropathogenic and enteroaggregative E. coli in stools of children with acute gastroenteritis in Davidson County, Tennessee. Diagn Microbiol Infect Dis 2015;83:319-24. [PMID: 26298817 DOI: 10.1016/j.diagmicrobio.2015.07.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
406 Kellnerová S, Chatterjee S, Bayarri-Olmos R, Justesen L, Talasz H, Posch W, Kenno S, Garred P, Orth-Höller D, Grasse M, Würzner R. Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines. Toxins (Basel) 2020;13:8. [PMID: 33374102 DOI: 10.3390/toxins13010008] [Reference Citation Analysis]
407 Kawahara R, Seto K, Taguchi M, Nakajima C, Kumeda Y, Suzuki Y. Characterization of Third-Generation-Cephalosporin-Resistant Shiga Toxin-Producing Strains of Escherichia coli O157:H7 in Japan. J Clin Microbiol 2015;53:3035-8. [PMID: 26135870 DOI: 10.1128/JCM.01263-15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
408 Buvens G, Bogaerts P, Glupczynski Y, Lauwers S, Piérard D. Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26. Antimicrob Agents Chemother 2010;54:4907-9. [PMID: 20733038 DOI: 10.1128/AAC.00551-10] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
409 Stigi KA, Macdonald JK, Tellez-Marfin AA, Lofy KH. Laboratory practices and incidence of non-O157 shiga toxin-producing Escherichia coli infections. Emerg Infect Dis 2012;18:477-9. [PMID: 22377034 DOI: 10.3201/eid1803.111358] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
410 Sükran K, Tatar B, Ersan G, Topaloğlu S. A leptospirosis case presenting with thrombotic thrombocytopenic purpura. Balkan Med J 2013;30:436-8. [PMID: 25207155 DOI: 10.5152/balkanmedj.2013.9078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
411 Kuo CJ, Wang ST, Chen CS. Detection of Enterohemorrhagic Escherichia Coli Colonization in Murine Host by Non-invasive In Vivo Bioluminescence System. J Vis Exp 2018. [PMID: 29683443 DOI: 10.3791/56169] [Reference Citation Analysis]
412 Melli LJ, Ciocchini AE, Caillava AJ, Vozza N, Chinen I, Rivas M, Feldman MF, Ugalde JE, Comerci DJ. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome. J Clin Microbiol 2015;53:528-38. [PMID: 25472487 DOI: 10.1128/JCM.02262-14] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
413 Werber D, Scheutz F. The importance of integrating genetic strain information for managing cases of Shiga toxin-producing E. coli infection. Epidemiol Infect 2019;147:e264. [PMID: 31496452 DOI: 10.1017/S0950268819001602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
414 Zhang W, Bielaszewska M, Bauwens A, Fruth A, Mellmann A, Karch H. Real-time multiplex PCR for detecting Shiga toxin 2-producing Escherichia coli O104:H4 in human stools. J Clin Microbiol 2012;50:1752-4. [PMID: 22337987 DOI: 10.1128/JCM.06817-11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
415 Miyajima K, Koshida T, Arakawa T, Kudo H, Saito H, Yano K, Mitsubayashi K. Fiber-Optic Fluoroimmunoassay System with a Flow-Through Cell for Rapid On-Site Determination of Escherichia coli O157:H7 by Monitoring Fluorescence Dynamics. Biosensors (Basel) 2013;3:120-31. [PMID: 25587403 DOI: 10.3390/bios3010120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
416 Vasant BR, Stafford RJ, Jennison AV, Bennett SM, Bell RJ, Doyle CJ, Young JR, Vlack SA, Titmus P, El Saadi D, Jarvinen KAJ, Coward P, Barrett J, Staples M, Graham RMA, Smith HV, Lambert SB. Mild Illness during Outbreak of Shiga Toxin-Producing Escherichia coli O157 Infections Associated with Agricultural Show, Australia. Emerg Infect Dis 2017;23:1686-9. [PMID: 28930030 DOI: 10.3201/eid2310.161836] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 9.3] [Reference Citation Analysis]
417 Lee SY, Cherla RP, Tesh VL. Simultaneous induction of apoptotic and survival signaling pathways in macrophage-like THP-1 cells by Shiga toxin 1. Infect Immun 2007;75:1291-302. [PMID: 17194804 DOI: 10.1128/IAI.01700-06] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
418 Uhlich GA, Andreozzi E, Cottrell BJ, Reichenberger ER, Zhang X, Paoli GC. Sulfamethoxazole - Trimethoprim represses csgD but maintains virulence genes at 30°C in a clinical Escherichia coli O157:H7 isolate. PLoS One 2018;13:e0196271. [PMID: 29718957 DOI: 10.1371/journal.pone.0196271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
419 Brigotti M, Carnicelli D, Ravanelli E, Vara AG, Martinelli C, Alfieri RR, Petronini PG, Sestili P. Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin. Infect Immun 2007;75:2201-7. [PMID: 17296757 DOI: 10.1128/IAI.01707-06] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
420 Bonanno L, Delubac B, Michel V, Auvray F. Influence of Stress Factors Related to Cheese-Making Process and to STEC Detection Procedure on the Induction of Stx Phages from STEC O26:H11. Front Microbiol 2017;8:296. [PMID: 28316592 DOI: 10.3389/fmicb.2017.00296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
421 Schimmer B, Nygard K, Eriksen HM, Lassen J, Lindstedt BA, Brandal LT, Kapperud G, Aavitsland P. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infect Dis 2008;8:41. [PMID: 18387178 DOI: 10.1186/1471-2334-8-41] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 7.8] [Reference Citation Analysis]
422 Poirier K, Faucher SP, Béland M, Brousseau R, Gannon V, Martin C, Harel J, Daigle F. Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect Immun 2008;76:4814-22. [PMID: 18725421 DOI: 10.1128/IAI.00446-08] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
423 Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T, Gear AR. Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun 2005;73:8306-16. [PMID: 16299328 DOI: 10.1128/IAI.73.12.8306-8316.2005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
424 Marcato P, Griener TP, Mulvey GL, Armstrong GD. Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia. Infect Immun 2005;73:6523-9. [PMID: 16177326 DOI: 10.1128/IAI.73.10.6523-6529.2005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
425 Havira MS, Ta A, Kumari P, Wang C, Russo AJ, Ruan J, Rathinam VA, Vanaja SK. Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS. Sci Immunol 2020;5:eabc0217. [PMID: 33246946 DOI: 10.1126/sciimmunol.abc0217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
426 Bletz S, Bielaszewska M, Leopold SR, Köck R, Witten A, Schuldes J, Zhang W, Karch H, Mellmann A. Evolution of enterohemorrhagic escherichia coli O26 based on single-nucleotide polymorphisms. Genome Biol Evol 2013;5:1807-16. [PMID: 24105689 DOI: 10.1093/gbe/evt136] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
427 DesRochers TM, Kimmerling EP, Jandhyala DM, El-Jouni W, Zhou J, Thorpe CM, Leong JM, Kaplan DL. Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue. Infect Immun 2015;83:28-38. [PMID: 25312954 DOI: 10.1128/IAI.02143-14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
428 Vera-Aguilera J, Duma N, Gast K, Alkhateeb H, Tande A, Leung N, Hogan WJ, Kenderian SJ. Hemolytic Uremic Syndrome Associated With Escherichia coli O157 Infection in an Allogenic Stem Cell Transplant Recipient. Mayo Clin Proc Innov Qual Outcomes 2018;2:387-91. [PMID: 30560242 DOI: 10.1016/j.mayocpiqo.2018.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
429 Motto D. Endothelial cells and thrombotic microangiopathy. Semin Nephrol 2012;32:208-14. [PMID: 22617770 DOI: 10.1016/j.semnephrol.2012.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
430 Jacob F, Hitchins MP, Fedier A, Brennan K, Nixdorf S, Hacker NF, Ward R, Heinzelmann-Schwarz VA. Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells. BMC Mol Biol 2014;15:24. [PMID: 25294702 DOI: 10.1186/1471-2199-15-24] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
431 Bunger JC, Melton-Celsa AR, Maynard EL, O'Brien AD. Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin. Toxins (Basel) 2015;7:2306-20. [PMID: 26110507 DOI: 10.3390/toxins7062306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
432 Petruzziello-Pellegrini TN, Moslemi-Naeini M, Marsden PA. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence 2013;4:556-63. [PMID: 23955166 DOI: 10.4161/viru.26143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
433 Matus V, Valenzuela JG, Hidalgo P, Pozo LM, Panes O, Wozniak A, Mezzano D, Pereira J, Sáez CG. Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4. PLoS One 2017;12:e0185431. [PMID: 28957360 DOI: 10.1371/journal.pone.0185431] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
434 Walsh PR, Johnson S. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome. Pediatr Nephrol 2019;34:1485-92. [PMID: 30058046 DOI: 10.1007/s00467-018-4025-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
435 Obrig TG, Karpman D. Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol 2012;357:105-36. [PMID: 21983749 DOI: 10.1007/82_2011_172] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
436 Germinario C, Caprioli A, Giordano M, Chironna M, Gallone MS, Tafuri S, Minelli F, Maugliani A, Michelacci V, Santangelo L, Mongelli O, Montagna C, Scavia G; all participants of the Outbreak investigation team. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing Escherichia coli O26:H11 in southern Italy, summer 2013. Euro Surveill 2016;21. [PMID: 27684204 DOI: 10.2807/1560-7917.ES.2016.21.38.30343] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
437 Rusconi B, Sanjar F, Koenig SS, Mammel MK, Tarr PI, Eppinger M. Whole Genome Sequencing for Genomics-Guided Investigations of Escherichia coli O157:H7 Outbreaks. Front Microbiol 2016;7:985. [PMID: 27446025 DOI: 10.3389/fmicb.2016.00985] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
438 Álvarez RS, Gómez FD, Zotta E, Paton AW, Paton JC, Ibarra C, Sacerdoti F, Amaral MM. Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome. Toxins (Basel) 2021;13:536. [PMID: 34437406 DOI: 10.3390/toxins13080536] [Reference Citation Analysis]
439 Bertin Y, Deval C, de la Foye A, Masson L, Gannon V, Harel J, Martin C, Desvaux M, Forano E. The gluconeogenesis pathway is involved in maintenance of enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. PLoS One 2014;9:e98367. [PMID: 24887187 DOI: 10.1371/journal.pone.0098367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
440 Rocha LB, Luz DE, Moraes CT, Caravelli A, Fernandes I, Guth BE, Horton DS, Piazza RM. Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities. Toxins (Basel) 2012;4:729-47. [PMID: 23105978 DOI: 10.3390/toxins4090729] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
441 Kehl A, Kuhn R, Detzner J, Steil D, Müthing J, Karch H, Mellmann A. Modeling Native EHEC Outer Membrane Vesicles by Creating Synthetic Surrogates. Microorganisms 2020;8:E673. [PMID: 32384757 DOI: 10.3390/microorganisms8050673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
442 Llanos A, Lee J, López F, Contreras C, Barletta F, Chea-Woo E, Ugarte C, Cleary TG, Ochoa TJ. Shiga toxin-producing Escherichia coli in Peruvian children with bloody diarrhea. Pediatr Infect Dis J 2012;31:314-6. [PMID: 22315000 DOI: 10.1097/INF.0b013e318244000c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
443 Smith AE, Kim SH, Liu F, Jia W, Vinogradov E, Gyles CL, Bishop RE. PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157:H7. J Biol Chem 2008;283:4332-43. [PMID: 18070877 DOI: 10.1074/jbc.M708163200] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
444 Xiong Y, Wang P, Lan R, Ye C, Wang H, Ren J, Jing H, Wang Y, Zhou Z, Bai X, Cui Z, Luo X, Zhao A, Wang Y, Zhang S, Sun H, Wang L, Xu J. A novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in China. PLoS One 2012;7:e36144. [PMID: 22558360 DOI: 10.1371/journal.pone.0036144] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
445 Schindler EI, Sellenriek P, Storch GA, Tarr PI, Burnham CA. Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. J Clin Microbiol 2014;52:3647-53. [PMID: 25078916 DOI: 10.1128/JCM.01231-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
446 Galarce N, Escobar B, Sánchez F, Paredes-Osses E, Alegría-Morán R, Borie C. Virulence Genes, Shiga Toxin Subtypes, Serogroups, and Clonal Relationship of Shiga Toxin-Producing Escherichia Coli Strains Isolated from Livestock and Companion Animals. Animals (Basel) 2019;9:E733. [PMID: 31569618 DOI: 10.3390/ani9100733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
447 Iwata K, Goto M. Did the ban on serving raw beef liver in restaurants decrease Enterohemorrhagic Escherichia coli infection in Japan?: an interrupted time-series analysis. BMC Infect Dis 2019;19:949. [PMID: 31703557 DOI: 10.1186/s12879-019-4576-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
448 Amaral MM, Girard MC, Álvarez RS, Paton AW, Paton JC, Repetto HA, Sacerdoti F, Ibarra CA. Ouabain Protects Human Renal Cells against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin. Toxins (Basel) 2017;9:E226. [PMID: 28718802 DOI: 10.3390/toxins9070226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
449 Tozzoli R, Grande L, Michelacci V, Ranieri P, Maugliani A, Caprioli A, Morabito S. Shiga toxin-converting phages and the emergence of new pathogenic Escherichia coli: a world in motion. Front Cell Infect Microbiol 2014;4:80. [PMID: 24999453 DOI: 10.3389/fcimb.2014.00080] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
450 Dorval G, Berteloot L, Pio L, Boyer O, Blanc T. A rare cause of transitory hematuria and urinary tract dysfunction in children: Answers. Pediatr Nephrol 2021;36:2131-5. [PMID: 33768327 DOI: 10.1007/s00467-021-05006-x] [Reference Citation Analysis]
451 Chase-Topping ME, Rosser T, Allison LJ, Courcier E, Evans J, McKendrick IJ, Pearce MC, Handel I, Caprioli A, Karch H, Hanson MF, Pollock KG, Locking ME, Woolhouse ME, Matthews L, Low JC, Gally DL. Pathogenic potential to humans of bovine Escherichia coli O26, Scotland. Emerg Infect Dis 2012;18:439-48. [PMID: 22377426 DOI: 10.3201/eid1803.111236] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
452 Silva MA, Santos ARR, Rocha LB, Caetano BA, Mitsunari T, Santos LI, Polatto JM, Horton DSPQ, Guth BEC, Dos Santos LF, Piazza RMF. Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay. Microorganisms 2019;7:E276. [PMID: 31438570 DOI: 10.3390/microorganisms7090276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
453 Müller D, Hagedorn P, Brast S, Heusipp G, Bielaszewska M, Friedrich AW, Karch H, Schmidt MA. Rapid identification and differentiation of clinical isolates of enteropathogenic Escherichia coli (EPEC), atypical EPEC, and Shiga toxin-producing Escherichia coli by a one-step multiplex PCR method. J Clin Microbiol 2006;44:2626-9. [PMID: 16825399 DOI: 10.1128/JCM.00895-06] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
454 Jenke C, Harmsen D, Weniger T, Rothganger J, Hyytia-Trees E, Bielaszewska M, Karch H, Mellmann A. Phylogenetic analysis of enterohemorrhagic Escherichia coli O157, Germany, 1987-2008. Emerg Infect Dis 2010;16:610-6. [PMID: 20350374 DOI: 10.3201/eid1604.091361] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
455 Kanayama A, Yahata Y, Arima Y, Takahashi T, Saitoh T, Kanou K, Kawabata K, Sunagawa T, Matsui T, Oishi K. Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010-2013. BMC Infect Dis 2015;15:539. [PMID: 26589805 DOI: 10.1186/s12879-015-1259-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
456 Hölzel CS, Tetens JL, Schwaiger K. Unraveling the Role of Vegetables in Spreading Antimicrobial-Resistant Bacteria: A Need for Quantitative Risk Assessment. Foodborne Pathog Dis 2018;15:671-88. [PMID: 30444697 DOI: 10.1089/fpd.2018.2501] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
457 Manning SD, Motiwala AS, Springman AC, Qi W, Lacher DW, Ouellette LM, Mladonicky JM, Somsel P, Rudrik JT, Dietrich SE, Zhang W, Swaminathan B, Alland D, Whittam TS. Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A 2008;105:4868-73. [PMID: 18332430 DOI: 10.1073/pnas.0710834105] [Cited by in Crossref: 336] [Cited by in F6Publishing: 299] [Article Influence: 24.0] [Reference Citation Analysis]
458 Xiaoli L, Figler HM, Goswami Banerjee K, Hayes CS, Dudley EG. Non-pathogenic Escherichia coli Enhance Stx2a Production of E. coli O157:H7 Through Both bamA-Dependent and Independent Mechanisms. Front Microbiol 2018;9:1325. [PMID: 29973923 DOI: 10.3389/fmicb.2018.01325] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
459 Griener TP, Strecker JG, Humphries RM, Mulvey GL, Fuentealba C, Hancock RE, Armstrong GD. Lipopolysaccharide renders transgenic mice expressing human serum amyloid P component sensitive to Shiga toxin 2. PLoS One 2011;6:e21457. [PMID: 21731756 DOI: 10.1371/journal.pone.0021457] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
460 Tremblay JM, Mukherjee J, Leysath CE, Debatis M, Ofori K, Baldwin K, Boucher C, Peters R, Beamer G, Sheoran A, Bedenice D, Tzipori S, Shoemaker CB. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2. Infect Immun 2013;81:4592-603. [PMID: 24082082 DOI: 10.1128/IAI.01033-13] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
461 Strachan NJ, Hunter CJ, Jones CD, Wilson RS, Ethelberg S, Cross P, Williams AP, MacRitchie L, Rotariu O, Chadwick D. The relationship between lay and technical views of Escherichia coli O157 risk. Philos Trans R Soc Lond B Biol Sci 2011;366:1999-2009. [PMID: 21624920 DOI: 10.1098/rstb.2010.0393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
462 Pollock KG, Young D, Beattie TJ, Todd WT. Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005. Epidemiol Infect 2008;136:115-21. [PMID: 17335633 DOI: 10.1017/S0950268807008217] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
463 Zhang Y, Liao YT, Sun X, Wu VCH. Is Shiga Toxin-Producing Escherichia coli O45 No Longer a Food Safety Threat? The Danger is Still Out There. Microorganisms 2020;8:E782. [PMID: 32455956 DOI: 10.3390/microorganisms8050782] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
464 Pedersen MG, Hansen C, Riise E, Persson S, Olsen KE. Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors. J Clin Microbiol 2008;46:2987-91. [PMID: 18650349 DOI: 10.1128/JCM.00871-08] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
465 Rivero MA, Passucci JA, Rodríguez EM, Parma AE. Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina. Eur J Clin Microbiol Infect Dis 2012;31:1131-5. [PMID: 21938536 DOI: 10.1007/s10096-011-1418-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
466 Smith MJ, Carvalho HM, Melton-Celsa AR, O'Brien AD. The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide. Infect Immun 2006;74:6992-8. [PMID: 17030576 DOI: 10.1128/IAI.01247-06] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
467 Hua Y, Chromek M, Frykman A, Jernberg C, Georgieva V, Hansson S, Zhang J, Marits AK, Wan C, Matussek A, Bai X. Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden. Virulence 2021;12:1296-305. [PMID: 33939581 DOI: 10.1080/21505594.2021.1922010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
468 Tsai HM. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med 2006;57:419-36. [PMID: 16409158 DOI: 10.1146/annurev.med.57.061804.084505] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
469 Li XY, Mai YF, Huang J, Pai P. Gastrointestinal infection-related disseminated intravascular coagulation mimicking Shiga toxin-mediated hemolytic uremic syndrome - implications of classical clinical indexes in making the diagnosis: A case report and literature review. World J Clin Cases 2019; 7(13): 1660-1670 [PMID: 31367625 DOI: 10.12998/wjcc.v7.i13.1660] [Reference Citation Analysis]
470 Shringi S, García A, Lahmers KK, Potter KA, Muthupalani S, Swennes AG, Hovde CJ, Call DR, Fox JG, Besser TE. Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models. Infect Immun 2012;80:369-80. [PMID: 22025512 DOI: 10.1128/IAI.05470-11] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
471 Bangayan NJ, Shi B, Trinh J, Barnard E, Kasimatis G, Curd E, Li H. MG-MLST: Characterizing the Microbiome at the Strain Level in Metagenomic Data. Microorganisms 2020;8:E684. [PMID: 32397065 DOI: 10.3390/microorganisms8050684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
472 Eaton KA, Friedman DI, Francis GJ, Tyler JS, Young VB, Haeger J, Abu-Ali G, Whittam TS. Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun 2008;76:3054-63. [PMID: 18443087 DOI: 10.1128/IAI.01626-07] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
473 Grisaru S. Management of hemolytic-uremic syndrome in children. Int J Nephrol Renovasc Dis 2014;7:231-9. [PMID: 24966691 DOI: 10.2147/IJNRD.S41837] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
474 Lee J, Bansal T, Jayaraman A, Bentley WE, Wood TK. Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl Environ Microbiol 2007;73:4100-9. [PMID: 17483266 DOI: 10.1128/AEM.00360-07] [Cited by in Crossref: 141] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
475 Pollock KG, Locking ME, Beattie TJ, Maxwell H, Ramage I, Hughes D, Cowieson J, Allison L, Hanson M, Cowden JM. Sorbitol-fermenting Escherichia coli O157, Scotland. Emerg Infect Dis 2010;16:881-2. [PMID: 20409394 DOI: 10.3201/eid1605.091919] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
476 Neher S, Hazarika AK, Barkalita LM, Borah P, Bora DP, Sharma RK. Isolation and characterization of Shiga toxigenic Escherichia coli of animal and bird origin by multiplex polymerase chain reaction. Vet World 2016;9:123-7. [PMID: 27051196 DOI: 10.14202/vetworld.2016.123-127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
477 Robinson JL, Brynildsen MP. Construction and Experimental Validation of a Quantitative Kinetic Model of Nitric Oxide Stress in Enterohemorrhagic Escherichia coli O157:H7. Bioengineering (Basel) 2016;3:E9. [PMID: 28952571 DOI: 10.3390/bioengineering3010009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
478 Mariani-Kurkdjian P, Lemaître C, Bidet P, Perez D, Boggini L, Kwon T, Bonacorsi S. Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype. New Microbes New Infect 2014;2:127-31. [PMID: 25356358 DOI: 10.1002/nmi2.49] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
479 Tarr GAM, Lin CY, Lorenzetti D, Chui L, Tarr PI, Hartling L, Vandermeer B, Freedman SB. Performance of commercial tests for molecular detection of Shiga toxin-producing Escherichia coli (STEC): a systematic review and meta-analysis protocol. BMJ Open 2019;9:e025950. [PMID: 30850413 DOI: 10.1136/bmjopen-2018-025950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
480 Lentz EK, Leyva-Illades D, Lee MS, Cherla RP, Tesh VL. Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2. Infect Immun 2011;79:3527-40. [PMID: 21708996 DOI: 10.1128/IAI.05139-11] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
481 Imamovic L, Tozzoli R, Michelacci V, Minelli F, Marziano ML, Caprioli A, Morabito S. OI-57, a genomic island of Escherichia coli O157, is present in other seropathotypes of Shiga toxin-producing E. coli associated with severe human disease. Infect Immun 2010;78:4697-704. [PMID: 20823207 DOI: 10.1128/IAI.00512-10] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
482 Kaper JB, Karmali MA. The continuing evolution of a bacterial pathogen. Proc Natl Acad Sci U S A 2008;105:4535-6. [PMID: 18353979 DOI: 10.1073/pnas.0801435105] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
483 Rodríguez-Rubio L, Muniesa M. Isolation and Characterization of Shiga Toxin Bacteriophages. Methods Mol Biol 2021;2291:119-44. [PMID: 33704751 DOI: 10.1007/978-1-0716-1339-9_5] [Reference Citation Analysis]
484 Tavasoli A, Zafaranloo N, Hoseini R, Otukesh H, Nakhaiee S. Frequency of neurological involvement in patients with/without diarrhea hemolytic uremic syndrome: A Systematic review and meta-analysis. Med J Islam Repub Iran 2021;35:91. [PMID: 34956937 DOI: 10.47176/mjiri.35.91] [Reference Citation Analysis]
485 Nolasco LH, Turner NA, Bernardo A, Tao Z, Cleary TG, Dong JF, Moake JL. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood 2005;106:4199-209. [PMID: 16131569 DOI: 10.1182/blood-2005-05-2111] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 6.0] [Reference Citation Analysis]
486 Tran SL, Jenkins C, Livrelli V, Schüller S. Shiga toxin 2 translocation across intestinal epithelium is linked to virulence of Shiga toxin-producing Escherichia coli in humans. Microbiology (Reading) 2018;164:509-16. [PMID: 29533744 DOI: 10.1099/mic.0.000645] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
487 Inns T, Cleary P, Bundle N, Foulkes S, Sharp A, Utsi L, McBrien C, Teagle R, Waldram A, Williams C, McCann C, Smith R, Saleh S, McCarthy N, Vivancos R, Hawker J, Decraene V. Novel application of the matched case-control design to compare food supply chains during an Escherichia coli O157 outbreak, United Kingdom, 2016. Euro Surveill 2018;23. [PMID: 29741154 DOI: 10.2807/1560-7917.ES.2018.23.18.17-00195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
488 Flowers LJ, Hu S, Shrestha A, Martinot AJ, Leong JM, Osburne MS. Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection. Methods Mol Biol 2021;2291:381-97. [PMID: 33704765 DOI: 10.1007/978-1-0716-1339-9_19] [Reference Citation Analysis]
489 Abu-Ali GS, Ouellette LM, Henderson ST, Lacher DW, Riordan JT, Whittam TS, Manning SD. Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS One 2010;5:e10167. [PMID: 20422047 DOI: 10.1371/journal.pone.0010167] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 4.9] [Reference Citation Analysis]
490 Nishida R, Nakamura K, Taniguchi I, Murase K, Ooka T, Ogura Y, Gotoh Y, Itoh T, Toyoda A, Mainil JG, Piérard D, Seto K, Harada T, Isobe J, Kimata K, Etoh Y, Hamasaki M, Narimatsu H, Yatsuyanagi J, Kameyama M, Matsumoto Y, Nagai Y, Kawase J, Yokoyama E, Ishikawa K, Shiomoto T, Lee K, Kang D, Akashi K, Ohnishi M, Iyoda S, Hayashi T. The global population structure and evolutionary history of the acquisition of major virulence factor-encoding genetic elements in Shiga toxin-producing Escherichia coli O121:H19. Microb Genom 2021;7. [PMID: 34878971 DOI: 10.1099/mgen.0.000716] [Reference Citation Analysis]
491 Sundström K. Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden. Appl Health Econ Health Policy 2018;16:243-57. [PMID: 29313242 DOI: 10.1007/s40258-017-0369-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
492 Dettmar AK, Binder E, Greiner FR, Liebau MC, Kurschat CE, Jungraithmayr TC, Saleem MA, Schmitt CP, Feifel E, Orth-Höller D, Kemper MJ, Pepys M, Würzner R, Oh J. Protection of human podocytes from shiga toxin 2-induced phosphorylation of mitogen-activated protein kinases and apoptosis by human serum amyloid P component. Infect Immun 2014;82:1872-9. [PMID: 24566618 DOI: 10.1128/IAI.01591-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
493 Kim SH, Ryu SH, Lee SH, Lee YH, Lee SR, Huh JW, Kim SU, Kim E, Kim S, Jon S, Bishop RE, Chang KT. Instability of toxin A subunit of AB(5) toxins in the bacterial periplasm caused by deficiency of their cognate B subunits. Biochim Biophys Acta 2011;1808:2359-65. [PMID: 21762677 DOI: 10.1016/j.bbamem.2011.06.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
494 Zangari T, Melton-Celsa AR, Panda A, Smith MA, Tatarov I, De Tolla L, O'Brien AD. Enhanced virulence of the Escherichia coli O157:H7 spinach-associated outbreak strain in two animal models is associated with higher levels of Stx2 production after induction with ciprofloxacin. Infect Immun 2014;82:4968-77. [PMID: 25225244 DOI: 10.1128/IAI.02361-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
495 Lee MS, Cherla RP, Leyva-Illades D, Tesh VL. Bcl-2 regulates the onset of shiga toxin 1-induced apoptosis in THP-1 cells. Infect Immun 2009;77:5233-44. [PMID: 19752028 DOI: 10.1128/IAI.00665-09] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
496 Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, Peters G, Karch H. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104: H4 strain. Antimicrob Agents Chemother. 2012;56:3277-3282. [PMID: 22391549 DOI: 10.1128/aac.06315-11] [Cited by in Crossref: 127] [Cited by in F6Publishing: 66] [Article Influence: 12.7] [Reference Citation Analysis]
497 Hazen TH, Michalski J, Nagaraj S, Okeke IN, Rasko DA. Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains. Antimicrob Agents Chemother 2017;61:e00995-17. [PMID: 28674052 DOI: 10.1128/AAC.00995-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
498 Wöchtl B, Gunzer F, Gerner W, Gasse H, Koch M, Bagó Z, Ganter M, Weissenböck H, Dinhopl N, Coldewey SM, von Altrock A, Waldmann KH, Saalmüller A, Zimmermann K, Steinmann J, Kehrmann J, Klein-Hitpass L, Blom J, Ehricht R, Engelmann I, Hennig-Pauka I. Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7. Gut Pathog 2017;9:30. [PMID: 28559930 DOI: 10.1186/s13099-017-0179-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
499 Moxley RA, Bargar TW, Kachman SD, Baker DR, Francis DH. Intimate Attachment of Escherichia coli O157:H7 to Urinary Bladder Epithelium in the Gnotobiotic Piglet Model. Microorganisms 2020;8:E263. [PMID: 32075320 DOI: 10.3390/microorganisms8020263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
500 Iguchi A, Iyoda S, Seto K, Morita-Ishihara T, Scheutz F, Ohnishi M; Pathogenic E. coli Working Group in Japan. Escherichia coli O-Genotyping PCR: a Comprehensive and Practical Platform for Molecular O Serogrouping. J Clin Microbiol 2015;53:2427-32. [PMID: 25926488 DOI: 10.1128/JCM.00321-15] [Cited by in Crossref: 71] [Cited by in F6Publishing: 35] [Article Influence: 10.1] [Reference Citation Analysis]
501 Adams NL, Byrne L, Smith GA, Elson R, Harris JP, Salmon R, Smith R, O'Brien SJ, Adak GK, Jenkins C. Shiga Toxin-Producing Escherichia coli O157, England and Wales, 1983-2012. Emerg Infect Dis 2016;22:590-7. [PMID: 26982243 DOI: 10.3201/eid2204.151485] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
502 Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol 2012;8:658-69. [PMID: 22986362 DOI: 10.1038/nrneph.2012.196] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 12.9] [Reference Citation Analysis]
503 MacDonald E, Dalane PK, Aavitsland P, Brandal LT, Wester AL, Vold L. Implications of screening and childcare exclusion policies for children with Shiga-toxin producing Escherichia coli infections: lessons learned from an outbreak in a daycare centre, Norway, 2012. BMC Infect Dis 2014;14:673. [PMID: 25518922 DOI: 10.1186/s12879-014-0673-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
504 Garimano N, Amaral MM, Ibarra C. Endocytosis, Cytotoxicity, and Translocation of Shiga Toxin-2 Are Stimulated by Infection of Human Intestinal (HCT-8) Monolayers With an Hypervirulent E. coli O157:H7 Lacking stx2 Gene. Front Cell Infect Microbiol 2019;9:396. [PMID: 31824869 DOI: 10.3389/fcimb.2019.00396] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
505 Zoja C, Buelli S, Morigi M. Shiga toxin triggers endothelial and podocyte injury: the role of complement activation. Pediatr Nephrol 2019;34:379-88. [PMID: 29214442 DOI: 10.1007/s00467-017-3850-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
506 O'Brien SJ. Foodborne zoonoses. BMJ 2005;331:1217-8. [PMID: 16308359 DOI: 10.1136/bmj.331.7527.1217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
507 Widgren S, Engblom S, Bauer P, Frössling J, Emanuelson U, Lindberg A. Data-driven network modelling of disease transmission using complete population movement data: spread of VTEC O157 in Swedish cattle. Vet Res 2016;47:81. [PMID: 27515697 DOI: 10.1186/s13567-016-0366-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
508 Giordano M, Baldassarre ME, Palmieri V, Torres DD, Carbone V, Santangelo L, Gentile F, Panza R, Di Mauro F, Capozza M, Di Mauro A, Laforgia N. Management of STEC Gastroenteritis: Is There a Role for Probiotics? Int J Environ Res Public Health 2019;16:E1649. [PMID: 31083597 DOI: 10.3390/ijerph16091649] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
509 Sauder AB, Kendall MM. After the Fact(or): Posttranscriptional Gene Regulation in Enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 2018;200:e00228-18. [PMID: 29967119 DOI: 10.1128/JB.00228-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
510 Gómez-Duarte OG. [Acute diarrheal disease caused by enteropathogenic Escherichia coli in Colombia]. Rev Chilena Infectol 2014;31:577-86. [PMID: 25491457 DOI: 10.4067/S0716-10182014000500010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
511 Laiko M, Murtazina R, Malyukova I, Zhu C, Boedeker EC, Gutsal O, O'Malley R, Cole RN, Tarr PI, Murray KF, Kane A, Donowitz M, Kovbasnjuk O. Shiga toxin 1 interaction with enterocytes causes apical protein mistargeting through the depletion of intracellular galectin-3. Exp Cell Res 2010;316:657-66. [PMID: 19744479 DOI: 10.1016/j.yexcr.2009.09.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
512 Maluykova I, Gutsal O, Laiko M, Kane A, Donowitz M, Kovbasnjuk O. Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells. Biochim Biophys Acta 2008;1782:370-7. [PMID: 18342638 DOI: 10.1016/j.bbadis.2008.01.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
513 Hirakawa H, Kurushima J, Hashimoto Y, Tomita H. Progress Overview of Bacterial Two-Component Regulatory Systems as Potential Targets for Antimicrobial Chemotherapy. Antibiotics (Basel) 2020;9:E635. [PMID: 32977461 DOI: 10.3390/antibiotics9100635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
514 Ledwaba SE, Becker P, Traore-Hoffman A, Potgieter N. Bacterial Contamination of Children's Toys in Rural Day Care Centres and Households in South Africa. Int J Environ Res Public Health 2019;16:E2900. [PMID: 31412661 DOI: 10.3390/ijerph16162900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
515 Tarr GAM, Oltean HN, Phipps AI, Rabinowitz P, Tarr PI. Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity. Int J Med Microbiol 2018;308:1121-7. [PMID: 30466555 DOI: 10.1016/j.ijmm.2018.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
516 Castro VS, Figueiredo EES, Stanford K, McAllister T, Conte-Junior CA. Shiga-Toxin Producing Escherichia Coli in Brazil: A Systematic Review. Microorganisms 2019;7:E137. [PMID: 31100803 DOI: 10.3390/microorganisms7050137] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
517 Vareille M, de Sablet T, Hindré T, Martin C, Gobert AP. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 2007;104:10199-204. [PMID: 17537918 DOI: 10.1073/pnas.0702589104] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
518 Desch K, Motto D. ADAMTS13 and VWF: not just for TTP anymore? Blood 2005;106:4024-4024. [DOI: 10.1182/blood-2005-09-3895] [Reference Citation Analysis]
519 Singh P, Teal TK, Marsh TL, Tiedje JM, Mosci R, Jernigan K, Zell A, Newton DW, Salimnia H, Lephart P, Sundin D, Khalife W, Britton RA, Rudrik JT, Manning SD. Intestinal microbial communities associated with acute enteric infections and disease recovery. Microbiome 2015;3:45. [PMID: 26395244 DOI: 10.1186/s40168-015-0109-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
520 Tourret J, Willing BP, Croxen MA, Dufour N, Dion S, Wachtel S, Denamur E, Finlay BB. Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on Its Extra-Intestinal Virulence Status. PLoS One 2016;11:e0153034. [PMID: 27096607 DOI: 10.1371/journal.pone.0153034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
521 Hua Y, Zhang J, Jernberg C, Chromek M, Hansson S, Frykman A, Xiong Y, Wan C, Matussek A, Bai X. Molecular Characterization of the Enterohemolysin Gene (ehxA) in Clinical Shiga Toxin-Producing Escherichia coli Isolates. Toxins (Basel) 2021;13:71. [PMID: 33477906 DOI: 10.3390/toxins13010071] [Reference Citation Analysis]
522 Lee JS, Yoon S, Han SJ, Kim ED, Kim J, Shin HS, Seo KY. Eyedrop vaccination: an immunization route with promises for effective responses to pandemics. Expert Rev Vaccines 2021;:1-11. [PMID: 34788181 DOI: 10.1080/14760584.2022.2008246] [Reference Citation Analysis]
523 Tyler JS, Beeri K, Reynolds JL, Alteri CJ, Skinner KG, Friedman JH, Eaton KA, Friedman DI. Prophage induction is enhanced and required for renal disease and lethality in an EHEC mouse model. PLoS Pathog 2013;9:e1003236. [PMID: 23555250 DOI: 10.1371/journal.ppat.1003236] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
524 Pacheco AR, Sperandio V. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2012;2:81. [PMID: 22919672 DOI: 10.3389/fcimb.2012.00081] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
525 Zweifel C, Cernela N, Stephan R. Detection of the emerging Shiga toxin-producing Escherichia coli O26:H11/H- sequence type 29 (ST29) clone in human patients and healthy cattle in Switzerland. Appl Environ Microbiol 2013;79:5411-3. [PMID: 23811503 DOI: 10.1128/AEM.01728-13] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
526 Mallick EM, McBee ME, Vanguri VK, Melton-Celsa AR, Schlieper K, Karalius BJ, O'Brien AD, Butterton JR, Leong JM, Schauer DB. A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest 2012;122:4012-24. [PMID: 23041631 DOI: 10.1172/JCI62746] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
527 Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008;23:1749-60. [PMID: 18704506 DOI: 10.1007/s00467-008-0935-6] [Cited by in Crossref: 183] [Cited by in F6Publishing: 140] [Article Influence: 13.1] [Reference Citation Analysis]
528 Bielaszewska M, Köck R, Friedrich AW, von Eiff C, Zimmerhackl LB, Karch H, Mellmann A. Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS One 2007;2:e1024. [PMID: 17925872 DOI: 10.1371/journal.pone.0001024] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
529 Kabiru LM, Bello M, Kabir J, Grande L, Morabito S. Detection of pathogenic Escherichia coli in samples collected at an abattoir in Zaria, Nigeria and at different points in the surrounding environment. Int J Environ Res Public Health 2015;12:679-91. [PMID: 25590145 DOI: 10.3390/ijerph120100679] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
530 Kurabayashi K, Hirakawa Y, Tanimoto K, Tomita H, Hirakawa H. Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake. J Bacteriol 2014;196:248-56. [PMID: 24163343 DOI: 10.1128/JB.01151-13] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
531 Schweppe CH, Hoffmann P, Nofer JR, Pohlentz G, Mormann M, Karch H, Friedrich AW, Müthing J. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J Lipid Res 2010;51:2282-94. [PMID: 20444989 DOI: 10.1194/jlr.M006759] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
532 Lee MS, Koo S, Jeong DG, Tesh VL. Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications. Toxins (Basel) 2016;8:E77. [PMID: 26999205 DOI: 10.3390/toxins8030077] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
533 Goldwater PN, Bettelheim KA. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med 2012;10:12. [PMID: 22300510 DOI: 10.1186/1741-7015-10-12] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
534 Balasubramanian S, Osburne MS, BrinJones H, Tai AK, Leong JM. Prophage induction, but not production of phage particles, is required for lethal disease in a microbiome-replete murine model of enterohemorrhagic E. coli infection. PLoS Pathog 2019;15:e1007494. [PMID: 30629725 DOI: 10.1371/journal.ppat.1007494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
535 Lo NC, Turner NA, Cruz MA, Moake J. Interaction of Shiga toxin with the A-domains and multimers of von Willebrand Factor. J Biol Chem 2013;288:33118-23. [PMID: 24097977 DOI: 10.1074/jbc.M113.487413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
536 Hunley TE, Spring MD, Peters TR, Weikert DR, Jabs K. Clostridium septicum myonecrosis complicating diarrhea-associated hemolytic uremic syndrome. Pediatr Nephrol 2008;23:1171-5. [PMID: 18301926 DOI: 10.1007/s00467-008-0774-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
537 Tesh VL. Induction of apoptosis by Shiga toxins. Future Microbiol 2010;5:431-53. [PMID: 20210553 DOI: 10.2217/fmb.10.4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
538 Lukyanenko V, Malyukova I, Hubbard A, Delannoy M, Boedeker E, Zhu C, Cebotaru L, Kovbasnjuk O. Enterohemorrhagic Escherichia coli infection stimulates Shiga toxin 1 macropinocytosis and transcytosis across intestinal epithelial cells. Am J Physiol Cell Physiol 2011;301:C1140-9. [PMID: 21832249 DOI: 10.1152/ajpcell.00036.2011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
539 Khan S, Mian HS, Sandercock LE, Chirgadze NY, Pai EF. Crystal structure of the passenger domain of the Escherichia coli autotransporter EspP. J Mol Biol 2011;413:985-1000. [PMID: 21964244 DOI: 10.1016/j.jmb.2011.09.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
540 Muniesa M, Hammerl JA, Hertwig S, Appel B, Brüssow H. Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology. Appl Environ Microbiol 2012;78:4065-73. [PMID: 22504816 DOI: 10.1128/AEM.00217-12] [Cited by in Crossref: 136] [Cited by in F6Publishing: 56] [Article Influence: 13.6] [Reference Citation Analysis]
541 Amézquita-Montes Z, Tamborski M, Kopsombut UG, Zhang C, Arzuza OS, Gómez-Duarte OG. Genetic Relatedness Among Escherichia coli Pathotypes Isolated from Food Products for Human Consumption in Cartagena, Colombia. Foodborne Pathog Dis 2015;12:454-61. [PMID: 25786140 DOI: 10.1089/fpd.2014.1881] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
542 Andreozzi E, Gunther NW 4th, Reichenberger ER, Rotundo L, Cottrell BJ, Nuñez A, Uhlich GA. Pch Genes Control Biofilm and Cell Adhesion in a Clinical Serotype O157:H7 Isolate. Front Microbiol 2018;9:2829. [PMID: 30532745 DOI: 10.3389/fmicb.2018.02829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
543 Liu B, Yin X, Feng Y, Chambers JR, Guo A, Gong J, Zhu J, Gyles CL. Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells. Appl Environ Microbiol 2010;76:4461-8. [PMID: 20453145 DOI: 10.1128/AEM.00182-10] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
544 Grys TE, Sloan LM, Rosenblatt JE, Patel R. Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. J Clin Microbiol 2009;47:2008-12. [PMID: 19439539 DOI: 10.1128/JCM.02013-08] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
545 Müsken A, Bielaszewska M, Greune L, Schweppe CH, Müthing J, Schmidt H, Schmidt MA, Karch H, Zhang W. Anaerobic conditions promote expression of Sfp fimbriae and adherence of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM to human intestinal epithelial cells. Appl Environ Microbiol 2008;74:1087-93. [PMID: 18083855 DOI: 10.1128/AEM.02496-07] [Cited by in Crossref: 38] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
546 Bielaszewska M, Stoewe F, Fruth A, Zhang W, Prager R, Brockmeyer J, Mellmann A, Karch H, Friedrich AW. Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J Clin Microbiol 2009;47:2061-6. [PMID: 19403777 DOI: 10.1128/JCM.00201-09] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
547 Schüller S, Phillips AD. Microaerobic conditions enhance type III secretion and adherence of enterohaemorrhagic Escherichia coli to polarized human intestinal epithelial cells. Environ Microbiol 2010;12:2426-35. [PMID: 20406285 DOI: 10.1111/j.1462-2920.2010.02216.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
548 Hua Y, Bai X, Zhang J, Jernberg C, Chromek M, Hansson S, Frykman A, Yang X, Xiong Y, Wan C, Matussek A. Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden. Emerg Microbes Infect 2020;9:2562-70. [PMID: 33179570 DOI: 10.1080/22221751.2020.1850182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
549 Ogura Y, Gotoh Y, Itoh T, Sato MP, Seto K, Yoshino S, Isobe J, Etoh Y, Kurogi M, Kimata K, Maeda E, Piérard D, Kusumoto M, Akiba M, Tominaga K, Kirino Y, Kato Y, Shirahige K, Ooka T, Ishijima N, Lee KI, Iyoda S, Mainil JG, Hayashi T. Population structure of Escherichia coli O26 : H11 with recent and repeated stx2 acquisition in multiple lineages. Microb Genom 2017;3. [PMID: 29208163 DOI: 10.1099/mgen.0.000141] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
550 Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, Peterson JM, Butani L, Jones DP, Havens PL, Patel HP, Wong CS, Andreoli SP, Rothbaum RJ, Beck AM, Tarr PI. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 2011;165:884-9. [PMID: 21784993 DOI: 10.1001/archpediatrics.2011.152] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
551 Kikuchi K, Lee K, Ueno H, Tomari K, Kobori S, Kaetsu A, Matsui M, Suzuki S, Sekizuka T, Kuroda M, Miyazaki M, Ohnishi M. Enterohaemorrhagic Escherichia coli O121:H19 acquired an extended-spectrum β-lactamase gene during the development of an outbreak in two nurseries. Microb Genom 2019;5. [PMID: 31215859 DOI: 10.1099/mgen.0.000278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
552 Zoufaly A, Cramer JP, Vettorazzi E, Sayk F, Bremer JP, Koop I, de Weerth A, Schmiedel S, Jordan S, Fraedrich K, Asselborn NH, Nitschke M, Neumann-Grutzeck C, Magnus T, Rüther C, Fellermann K, Stahl RK, Wegscheider K, Lohse AW. Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection. PLoS One 2013;8:e59209. [PMID: 23533606 DOI: 10.1371/journal.pone.0059209] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
553 Pradhan S, Pellino C, MacMaster K, Coyle D, Weiss AA. Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease. Front Cell Infect Microbiol 2016;6:114. [PMID: 27747196 DOI: 10.3389/fcimb.2016.00114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
554 González DP, Iglicki M, Svetitsky S, Bar-On Y, Habot-Wilner Z, Zur D. Occlusive retinal vasculopathy with macular branch retinal artery occlusion as a leading sign of atypical hemolytic uremic syndrome - a case report. BMC Ophthalmol 2021;21:65. [PMID: 33516177 DOI: 10.1186/s12886-021-01820-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
555 Bielaszewska M, Prager R, Vandivinit L, Müsken A, Mellmann A, Holt NJ, Tarr PI, Karch H, Zhang W. Detection and characterization of the fimbrial sfp cluster in enterohemorrhagic Escherichia coli O165:H25/NM isolates from humans and cattle. Appl Environ Microbiol 2009;75:64-71. [PMID: 18978078 DOI: 10.1128/AEM.01815-08] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
556 Huang J, Haberichter SL, Sadler JE. The B subunits of Shiga-like toxins induce regulated VWF secretion in a phospholipase D1-dependent manner. Blood 2012;120:1143-9. [PMID: 22718838 DOI: 10.1182/blood-2012-01-408096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]